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Abstract 
Bacterial LPS as the immune modulating component in  
Juzen-taiho-to 
By  
Diego Montenegro 
Advisor: Dr. Akira Kawamura 
 
Juzen-taiho-to (JTT) is an immune-boosting herbal formulation with an ideal 
balance of safety and efficacy. For example, JTT is clinically used in Japan to stimulate 
the immunological functions of cancer patients undergoing chemotherapy and radiation. 
Although the clinical effects of JTT are recognized, the active compounds and 
mechanism of action are unknown. The studies conducted previously in our laboratory 
associated several phytosterols and plant glycolipids with the potent immunostimulatory 
activity of JTT: namely, β-sitosteryl β-D-glucoside (BSSG), glucocerebroside (GluCer), 
digalactosyldiacylglycerol (DGDG) and monogalactosyldiacylglycerol (MGDG). 
However, these compounds, when further purified, exhibited little or no 
immunostimulatory activity. This suggested that the immunostimulatory factors in JTT 
(1) had similar physicochemical properties as phytosterols and glycolipids; (2) existed in 
very small quantities, and (3) were extremely potent. These attributes led us to the 
hypothesis that the immunostimulatory factors of JTT stemmed not from plant 
metabolites but from bacterial glycolipids, some of which were known for potent 
immunostimulatory activity.  
 v 
This hypothesis was tested in the first half of my thesis work. Through a series of 
chemical and biochemical studies, including chemical extraction and high resolution 
mass spectrometry (MS), the main immunostimulatory factor of JTT was identified as 
lipopolysaccharide (LPS) of Gram-negative bacteria. Detailed chemical and 
immunological characterization of LPS in JTT, however, was hampered by their 
heterogeneity and minuscule quantities. In order to gain insights into the LPS in JTT, we 
decided to characterize microbial community in JTT by Illumina sequencing. 16S 
metagenomic sequencing of Angelica sinensis, which is a JTT component with most 
potent immunostimulatory activity, revealed Rahnella aquatilis as the main Gram-
negative species. The finding of R. aquatilis in JTT was surprising because LPS produced 
by R. aquatilis exhibit endotoxicity, yet JTT does not.  
The finding of LPS in JTT opened the possibility that plant metabolites might 
modulate the activity of LPS. In order to gain insights into this possible interaction 
between LPS and plant metabolites, the second half of my thesis work focused on 
chemical and immunological characterization of LPS-plant metabolite mixtures. Since 
LPS was known to form nanoparticles in aqueous solution, I hypothesized that plant 
metabolites would affect LPS nanoparticle assembly, which, in turn, could modulate 
immunostimulatory activity. My thesis work mainly focused on the LPS and BSSG 
mixture, because BSSG was the most prominent plant metabolite in the 
immunostimulatory fractions purified from JTT. Cell-based assays showed that BSSG 
significantly modulated the immunostimulatory activity of LPS. On the other hand, 
dynamic light scattering and transmission electron microscope also revealed that BSSG 
significantly modulated the nanoscale assembly of LPS. Taken together, these results 
 vi 
suggested that the supramolecular assembly of the BSSG/LPS mixture was a key 
determinant of its immunomodulatory activity.  
Collectively, this thesis work provided a new molecular basis to understand the 
safe and effective immunostimulatory effects of JTT and other immune-boosting 
medicinal plants.  
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Chapter 1 Juzen-taiho-to as an immunostimulatory herb 
1.1. Herbal medicine.  
Herbs are the source of many modern medicines used today, such as the anti-
inflammatory drug aspirin from the willow tree leaves, anticancer drug paclitaxel from 
the bark of the pacific yew tree and antimalarial drug quinine from the bark of the 
cinchona tree. The use of herbal medicine can be traced back to the Paleolithic age and 
documentation of its uses, with the earliest recorded concoctions coming from 
Mesopotamia and China, found as early as 2600 BC [1]. The relevance of herbal 
medicine and the importance of such studies was recently recognized at the 2015 Nobel 
Prize, shared by Dr. Youyou Tu for the discovery of Artemisinin [2] (Figure 1.1). Dr. Tu 
and her group found in a 1600-year-old text that sweet wormwood, Artemisia annua, was 
utilized to treat malaria. Following the historical clues from the text, she used a scientific 
approach to isolate and test the compounds from the known plant. Her search using 
Traditional Chinese Medicine (TCM) literature produced an antimalarial drug that is 
effective against malaria cases that are resistant to the widely used chloroquine. The 
global implications of these discoveries on human health underscore the importance of 
herbal medicine as source of modern drugs.  
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Figure 1.1. Artemisinin Structure. Isolated from Artemisia annua, this sesquiterpene lactone 
targets plasmodium falciparum, the parasite causing malaria. The peroxide bridge is believed to 
be important in the mode of action of artemisinin [3]. 
 
 Herbal medicine has a long tradition in different cultures and for the treatment of 
various diseases. The list of countries that use some kind of medicinal herb is extensive, 
with multiple plants being used either alone or in combination with other herbs. Although 
many countries and cultures have their own plant preparations, none have been able to 
establish a more systematic approach to herbal medicine than the Japanese herbal 
community [4]. Since TCM was introduced in Japan, it evolved into a more standardized 
and controlled system which became known as Kampo medicine. Kampo medicine is 
supported and regulated by the Japanese government, therefore it is highly integrated in 
the national health care system. In Kampo medicine, the methodology of preparation 
requires established ingredients in standardized ratios, making it easier to study various 
drugs to assess their mechanisms of function.  
Kampo medicine differs from Western medicine in that Western medicine often 
works by aiming at one target (e.g receptor)to treat disease, while Kampo medicine is 
more holistic and aims to affect multiple targets that are involved in and control 
homeostasis. By having multiple targets, Kampo medicines have the ability to affect 
physiological systems like immune, endocrine, hematopoietic, and nervous systems as 
whole. Out of all 210 herbal formulas found on Kampo medicine, Juzen-Taiho-To (JTT) 
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stands out for its versatility and safety. In fact, JTT is an immune boosting herbal 
formulation that is used in a range of different therapies and its formulation has also been 
shown to protect against Alzheimer’s disease [5].  
 
1.2. Juzen-Taiho-To  
JTT was first described in the 12th century by Chinese Pharmacopeia and it is 
composed of 10 different herbs, namely Peony Root, Cinnamon Bark, Astragali Radix, 
Hoelen, Rehmanniae Radix, Angelica Radix, Ginseng Radix, Cnidium Rhizome, 
Glycyrrhizae Radix, and Atractylodes Rhizome (Figure 1.2).  
 
 
Figure 1.2. Juzen-taiho-to composition.  List of the 10 herbal components of JTT which 
includes roots, stem, bark and a parasitic fungus. 
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Clinical studies have shown the efficacy of JTT for the treatments of numerous 
illnesses, such ulcerative colitis, anal fistulas, chronic sinusitis, stomatitis, anemia, 
chronic otitis media, and pyorrhea [6]. It also has an important role in cancer treatment 
[7-10] (Figure 1.3) where it is commonly used because it improves the patient’s general 
condition before and after surgery. In addition, JTT helps prevent the side effects of 
chemotherapy and causes overall improvement after radiotherapy treatment [9]. The 
positive clinical results and their reproducibility lead to an increase in interest in the 
mode of action of JTT.  Its effectiveness in alleviating symptoms in different conditions 
may be attributed to multiple constituents in the JTT mixture and the complexity of their 
interactions with the immune system. 
To discern how JTT works, preclinical studies have been performed in-vitro as 
well as in animal models. Several studies have shown JTT to induce the proliferation and 
differentiation of hematopoietic cells like monocytes and macrophages. [11, 12]. For 
example, an in-vitro study has shown that bone marrow cells from mice proliferated in a 
dose dependent manner upon JTT treatment [13].  More importantly, animal studies have 
shown that JTT has the ability to activate antigen-presenting cells (APC) [7]. In this 
study, mice were inoculated with colon cancer cells and JTT fed mice showed less tumor 
colonies in the liver and greatly decreased metastasis when compared to untreated 
control,. The effects of JTT were greatly reduced when the JTT fed mice were treated 
with 2-chloroadenosine, known to destroy macrophages. The effects of JTT were also 
reduced on T-cell deficient mice [7, 12]. (Figure 1.3 and Figure 1.5). This studies 
confirmed the role of JTT in macrophage activation. This is important because APC cells 
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are part of the first layer of protection of the immune system, the innate immune 
response.  
 
 
Figure 1.3. JTT activity in mice. JTT ability to activate macrophages was shown by testing the 
activity of JTT prior and after the addition of 2-chloroadenosine to the mouse diet.  2-
choloroadenosine is used to deplete macrophage population. JTT had no effect in decreasing 
metastasis on mice with 2-chloroadenosine depleted macrophage population. This study 
suggested the link between JTT and macrophage activation [7, 12]. 
 
1.3. Objective, central hypothesis and significance 
Although the medicinal effects of JTT are well documented, the recipe 
standardized and some of its cellular targets known, understanding the mechanism of 
action of JTT is complicated because different batches of JTT may have different 
therapeutic efficiency. Therapeutic effects of individual herbs depend on various factors, 
such as time of harvest, soil composition, and local climate where the herbs were grown. 
This is a significant issue for clinical use because the same plants can have a variable 
therapeutic efficacy depending on the variations in these conditions. Hence standardizing 
the ratio of herbs used in the mixture may not be enough to ensure consistent clinical 
effectiveness. 
Another important issue is that despite JTT being a medicine with well-
established beneficial effects, it shows adverse interactions with other drugs. One such 
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example is the interaction of JTT with the anticancer drug Tamoxifen. Tamoxifen works 
by inhibiting the growth of breast cancer cells by lowering estrogen levels in estrogen 
positive breast cancer patients. The effect of tamoxifen can be antagonized by the 
estrogenic activity of JTT [9].  
Studying the active compounds of JTT can be challenging due to the complexity 
of the concoction. It is recognized that the efficacy of JTT, as well as of other Kampo 
formulations, cannot be easily explained by the sole pharmacological activity of any one 
of the active factors, as these factors may have an effect on multiple systems. However, a 
deeper understanding of the herbs, including origin and history of the different 
components and how they function in the mixture independently and with each other is 
needed to optimize the therapeutical performance of the herbal medicine and to identify 
and minimize the undesirable cross-interaction between JTT and other treatments. 
Specifically, the knowledge gap that needs to be filled centers on the molecular activity 
of the herbal mixture.  
A few preclinical studies have started to define the cellular targets of the drug, but 
in order to understand how JTT works, the molecular mechanism of immunostimulation 
needs to be deciphered (Figure 1.4). Mechanistic understanding is necessary because this 
could direct the creation of a safer and more standardized products and potentially 
simplify and optimize medicine production by avoiding unnecessary and undesired 
constituents. Thus, standardization is critical for properly exploiting the many therapeutic 
benefits of JTT.  
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Figure 1.4. Knowledge gap in JTT targets and function. Clinical studies have shown the 
effects of JTT in cancer treatment, and immune stimulation. Preclinical studies gave a better 
understanding of JTT by determining the cellular targets of the drug. Molecular targets and 
molecular understanding of JTT are, however, still limited. These include active components, 
component interactions and specific cellular targets. This knowledge would greatly improve the 
safety and efficacy of the medicine. 
 
The first important step in understanding JTT mechanism is identifying the active 
factors that make JTT an immunostimulant. Previous studies suggested carbohydrates, 
such pectins, as the possible immunostimulants in JTT [6]. These carbohydrates rich 
extracts were not fully purified, leaving the door open to other immunoactive JTT 
components. We propose that more lipophilic immunoactive compounds may have been 
undetected in earlier extracts, and chose to revisit the mixture.  
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1.4. Current work on understanding JTT mechanism. 
Earlier preclinical experiments, suggested that the activity of JTT is caused by 
activation of Antigen Presenting Cells (APCs) [6, 7, 12]. The APCs in the innate immune 
system recognize pathogens’ unique surface molecules, which are called pathogen 
associated molecular pattern (PAMP). PAMPs represent the non-self molecules, such as 
carbohydrates, peptidoglycans, and lipopeptides found on the surface of pathogens such 
as fungi, viruses and bacteria. One of the most well-known PAMPs is bacterial 
lipopolysaccharide (LPS). LPS is found on the bacteria cell membrane and is 
recognized by the Toll-like Receptor complex CD14/TLR4/MD2 on APCs. In addition, 
NOD-like receptors (NLR) are able to identify intracellular LPS. Other TLRs that 
recognize various other pathogens’ molecules, such as lipids and oligonucleotides can 
also be present on APCs.  
PAMPs recognition by the TLRs activates APC immunoactivity through the NF-
ĸB pathway. For more details see Figure 1.5.  
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Figure 1.5. Recognition of pathogens by Antigen presenting cells. a. Pattern Recognition 
Receptors (PRRs) are able to physically recognize elements found on the pathogen’s surface 
(PAMPs). This recognition leads to the activation of the APC through NF-ĸB pathway and 
release of cytokines. b. Upon activation, APC become phagocytic and clear pathogens more 
efficiently. They also present T cells with fragments of the pathogens through the Major 
Histocompatibility Complex (MHC), which leads to the activation of the adaptive immune 
response. 
 
For our study, we decided against the use of animal models because of the 
complexity of the herbal mixture and reproducibility issues mentioned in the previous 
section. As the preclinical experiments determined that the activity of JTT is due to APCs 
activation we chose to test the activity of JTT on a cell-based assay. The use of primary 
cells (dendritic cells, macrophages and monocytes) was not feasible for our mechanistic 
Clearance 
of 
pathogens 
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studies due to the difficulty in isolating and growing them in the lab. We, thus, focused 
on cancerous cells as there are multiple lines that are easily grown in the lab and sensitive 
to immunostimulating factors. Notwithstanding their cancerous origin, THP-1 cells 
response to JTT correlates very well with primary cells [14]. Dr. Hasson, a former 
member of the lab, tested the immune response in various tumor lines. Based on his 
results THP-1 cell line was chosen to test for JTT immunological effects. THP-1 cells are 
human monocytic leukemia cells, and they are easily grown in the lab. They can be easily 
differentiated into dendritic-like cells and macrophage-like cells, and they respond to a 
variety of immunostimulating factors.  
The next step was to find a reliable marker to test for immunostimulation. For this 
purpose, we performed a genomic screening of THP-1 cells after treatment with JTT 
against vehicle control. In this procedure, gene-chip oligonucleotide array in tandem with 
qRT-PCR revealed multiple genes that were downstream of nuclear factor kappa B (NF-
kB) pathway and were differentially regulated upon immunostimulation. Some of these 
genes are: ICAM-1, IL-1B, TNF-α [15, 16]. ICAM-1 was chosen as the most reliable 
marker for JTT activity [14, 17].  
 
Table 1.1. Structure of glycolipids and phytosterols found on JTT 
Structure Name 
 
monostearin 
 
stearic acid 
 
monobehenine 
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monopalmitin 
 
palmitic acid 
 
-glucocerebrosides (4-trans, 8-
cis/trans) 
 
stigmateryl -D-glucoside 
 
-sitosteryl -D-glucoside 
(BSSG) 
 
monogalactosyldiacylglycerol 
(MGDG) 
 
digalactosyldiacylglycerol 
(DGDG) 
 
In our original foray into isolating and characterizing JTT active factors and 
function, we succeeded in enriching the APC stimulatory fraction. Analysis of the 
enriched fraction by LC-MS showed large amounts of phytosterols, a cholesterol like 
plant compounds, and several glycolipids. The compounds found were: monostearin, 
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stearic acid, monobehenine, monopalmitin, palmitic acid, -glucocerebrosides (4-trans, 
8-cis/trans), stigmateryl -D-glucoside, and -sitosteryl -D-glucoside (BSSG). (Table 
1.1) 
The characterization of the isolated constituents showed limited activity either 
individually or in combination. β-glucocerebrosides had  modest activity when compared 
to JTT, while all the other glycolipids had either marginal or no activity [14, 18].  
As our efforts were successful in isolating important components of JTT, but not 
equally successful in replicating JTT activity and as we were still unable to identify the 
elusive active compound from the mixture, we surmised that the isolation techniques 
used to separate and identify the active compound were not sensitive enough. 
Considering the complexity of the sample and the heterogeneity of the JTT mixture it was 
possible that the concentration of the unknown stimulant was low, a possibility that 
intriguingly hinted at the potency of the molecule itself.  
The isolation and analysis of the compounds in JTT, however, provided us with 
valuable methods and insight form future studies. We inferred that based on the chemical 
structure and polarity of the molecules found on the active fraction, the missing factor 
most likely had a similar structure to glycolipids. It was also concluded that the active 
compound was extremely potent as we were able to observe and quantify its effects in 
our cell assay even though not enough of it was obtained through the enrichment to be 
seen by LC-MS analysis. This information lead to new approach to identify this unknown 
glycolipid.  
This work will touch on the study of immunoactive JTT components. Chapter 2 
discusses how the active compound in JTT was finally identified, and how it was found 
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to originate from an unexpected source, bacteria. Chapter 3 discusses how the bacteria at 
the origin of the active compound was identified. Chapter 4 discusses the interaction of 
our active compound with the other components from JTT, how this interaction can 
modulate the glycolipid immune activity, and how this discovery is driving the 
understanding of the supramolecular assembly of glycolipids. Finally, Chapter 5 would 
give an idea on the future directions that this study coud take. 
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Chapter 2 Identification of Lipid A, key glycolipid in JTT 
2.1. Introduction 
Juzen-Taiho-to, a popular herbal formulation in Japan, has documented immune-
boosting effects [1-6]. Our lab recognized JTT as a potential source of immuneactivating 
compounds, and efforts were made to isolate these compounds. By means of 
fractionation, chromatographic methods and chemical analysis, our group discovered that 
β-sitosteryl β-D-glucoside (BSSG) and stigmateryl β-D-glucoside were the most 
prevalent components in the active fraction (see Table 1.1 in Chapter 1). Other 
compounds uncovered as part of the active fraction [7, 8] were: monostearin, stearic acid, 
monobehenine, monopalmitin, palmitic acid, β-glucocerebrosides (8-cis and 8-trans 
isomers). During fractionation, the mixture of these compounds showed 
immunostimulatory activity on THP-1 cells. However, when the purified glycolipids 
were tested individually, most of them had marginal or no measurable activity. This 
intriguing finding opened the possibility of a missing factor yet to be discovered in JTT.  
Other groups have also sought out the active compounds and some progresses 
have been made. For example, Yamada et al.  endeavored to isolate the active factors by 
fractionating the methanol extract of JTT and subsequently followed the fractions’ 
activity by monitoring lymphocyte proliferation. The study showed the presence of 
palmitic acid, stearic acid, oleic acid, and linolenic acid [5] in the active fraction.  -
sitosterol was also found to be one of the components in the active proliferating fraction. 
For the activity study, oleic acid and linoleic acid showed twice the proliferation 
compared to the control. Palmitic acid and stearic acid showed moderate proliferation. -
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sitosterol caused no proliferation. Although some of these lipids showed activity, the 
authors did not specify if the proliferation was comparable to whole JTT’s. 
Even though our initial search for the main active components in JTT was 
unsuccessful, it left us with some important clues [8]. We learned that the 
immunostimulant candidate would most likely have a glycolipid framework. Glycolipids 
are amphipathic molecules, with a polar head and non-polar lipid tale, therefore the 
candidate immostimulant should have similar polarity as glycolipids. Furthermore, the 
candidate factor must be very potent because it had immunostimulatory effect even when 
diluted to an extent that there was lack of clear of signals from this unknown molecule on 
HPLC as well as MS. With this in mind, we hypothesized that the mysterious immune 
stimulating factor would be lipid A (LA), a bacterial product obtained from the 
hydrolysis of lipopolysaccharide (LPS). Our hypothesis was supported by the LPS-like 
activity of JTT [1, 3, 9]. Both JTT and LPS induce similar gene expression profiles on 
macrophages [8, 10]. LPS is a large glycolipid that covers the outer surface of gram-
negative bacteria. LA is the inner glycolipid moiety responsible for the well-known 
immunostimulatory activity of LPS (Figure 2.1) [11-14]. The hypothesis was based on 
the fact that plants harbor a wide variety of gram-negative phytobacteria, which produce 
structurally diverse LA variants. LA is a known bacterial product, and JTT components 
are mostly roots, making it very likely that phytobacteria could be present as part of the 
herbal mixture. Even though there are multiple pathogenic bacteria that attack and harm 
the plants, there are others that are very important for its health and growth. 
Rhizobacteria for example are able to enhance the growth of the plant by helping the 
plant absorb substrates from the soil with the help of siderophores and affecting soil pH 
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[15-18]. Plants are known to nurture bacteria that can fix nitrogen [19, 20] and protect 
them from other harmful plant pathogens [21].  
Our hypothesis was also supported by the studies on immune-boosting herb 
Echinacea. Studies by Pasco and co-workers showed that bacteria load correlated to the 
macrophage activity of Echinacea [22]. Further studies also showed that the activity of 
Echinacea decreased when exposed to Polymyxin B (pmxB), a LA binding peptide [23, 
24]. Taken together, the data from our lab and from others strongly supported the idea 
that LA was the cause of the immune-boosting activity of JTT. 
The first step to test our hypothesis was to test for the presence of bacterial LPS in 
the sample; hence, we subjected JTT to chromogenic limulus amebocyte lysate (LAL) 
assay [25]. LAL assay detects endotoxic LPSs of human pathogenic gram-negative 
bacteria, which trigger potent and toxic pro-inflammatory responses. LAL assay, 
however, does not detect many structural variants of LPS, including non-endotoxic LPS 
produced by phytobacteria. It was previously found that the endotoxicity of JTT is lower 
than the detection limit for the assay [26]. The LAL assay confirmed that endotoxins 
level could not account for the potent immunostimulatory activity of JTT. As such, we 
concluded that the activity of JTT was not due to common bacterial contamination (such 
as, E. coli). Instead, the presence of immunostimulatory phytobacteria in JTT was 
confirmed. 
LA is obtained from the hydrolysis of LPS under acidic conditions. Besides LA, 
LPS consists of a core polysaccharide and the O-antigen repeat. The O-antigen repeat is 
the most variable segment of LPS, and in association with the core polysaccharide it 
gives LPS its hydrophilic characteristic. The LA segment serves to anchor LPS in the 
 18 
bacterial membrane due to its hydrophobicity. The LA backbone consist of two 
glucosamine molecules, two to one phosphate groups and 4 to 6 acyl chains, 6 being the 
most common (Figure 2.1a). The biosynthesis of the LA fragment has been extensively 
studied [27-29], and each bacterium can have multiple LA isoforms at any given time. 
LA structure is also dynamic; it can change in response to environment stimuli. One 
example is LA found in Yersenia pestis, the bacteria that causes bubonic plague. Y. pestis 
is able to detect changes in temperature, adapting and modifying its LA. This is important 
because Y. pestis uses fleas as a vector for infection, and the body temperature of fleas is 
< 30ºC. At this temperature Y. pestis LA is hexaacylated, and is unrecognized by the 
flea’s immune system (Figure 2.1b). In humans, Y. pestis is able to avoid recognition of 
the innate immune system by partially deacetylating LA. By becoming tetraacylated at 
37ºC (human body temperature) Y. pestis LA is not only not recognized by macrophages, 
but it becomes antagonistic to LA receptors (TLR4), preventing phagocytosis and 
suppressing inflammation [30] (Figure 2.1c). There are other examples of bacteria that 
modify their LA structure to evade the innate immune cells, and they achieve it by 
substituting the phosphate groups and avoiding the presence of cationic peptides [31, 32].  
 
 19 
 
Figure 2.1. Structures of Lipopolysaccharide (LPS) and Lipid A (LA). a. Structural scheme 
of LPS from E. coli K12 [33]. Structure of LPS is divide into 3 parts: O-Antigen repeat, Core 
polysaccharide and Lipid A. The monosaccharides shown in the structure are 3-deoxy-D-manno-
oct-2-ulosonic acid (Kdo); L-gycero-D-manno-heptose (Hep); Glucose (Glu); Galactose (Gal); 
Ethanolamine (Etn); and Phosphate group (P) b. LA structure of Y. pestis from the wild type, 
after growing at 20-28ºC. Hexaacylated LA, in which there are two 4-amino-4-deoxy-L-arabinose 
(Ara4N) added to the phosphate groups [30, 34, 35] c. Tetraacylated LA of Y. pestis from the 
wild type, after growing at 37ºC. 
 
In humans LPS is detected by APCs, such as monocytes, macrophages as well as 
dendritic cells. APCs physically recognize bacteria by identifying pathogen-associated 
molecular patterns (PAMPs) on the pathogen’s exterior. To achieve this, phagocytic cells 
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display pattern recognition receptors (PRRs) that are specific for PAMPs. The most 
famous example of a PAMP is the LPS found on gram-negative bacteria. LPS is 
recognized by monocytes/macrophages by the Toll like receptor 4 (TLR4) in conjunction 
with MD-2, CD14 and LPS Binding Protein (LBP) [36-39] (Figure 2.2). LPS recognition 
leads to inflammation and T-cell activation [40-43]. In the case of TLR4 and LPS, the 
interaction triggers a cascade of signals leading to the downstream activation of NF-B 
(nuclear factor kappa-light-chain-enhancer of activated B cells) [44] and cytokine release. 
Cytokines are the chemicals in charge of communication between the innate and acquired 
immune response. LPS can also mediate NF-B activation through TLR2 receptors. LPS 
binding can trigger the release of pro-inflammatory cytokines, eicosanoids and nitric 
oxide.  This causes inflammation that can lead in extreme cases of sepsis [28, 45]. LPS 
identification through TLR is not the only way LPS is detected. There is also TLR4 
independent recognition, mediated by the non-canonical inflammasome pathway, which 
functions by detecting LPS intracellularly [46, 47]. Non-canonical inflammasome is 
mediated by caspase-11, instead of caspase-1, associated to TLR4. 
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Figure 2.2. TLR4 activation by LPS. LPS/LA is first detected by LBP (not shown) which 
moves it to CD14 and MD-2. This triggers the activation of TLR4 through its interaction with 
MD-2/LPS and CD14 which causes the dimerization on TLR4. Once TLR4 is dimerized, the 
complex intracellular domain interacts with the TRAM/TRIF complex as well as the 
TIRAP/MyD88 complex. The TRAM/TRIF complex binding to the receptor causes the nuclear 
factor IRF3 to travel into the nucleus and promote the expression of type I interferons. Interferons 
are used for cell to cell communication; in this case it leading to the activation of T-cells and B-
cells. When TIRAP/MyD88 binds to the receptor, nuclear factor NF-B gets activated which in 
turn leads to the transcription of proinflammatory cytokines and chemokines. TLR4 can also be 
activated while endocytosed. This event leads to the activation of IRF3 only. 
 
Macrophages and dendritic cell reply to LPS by coordinating the innate immune 
response as well as the adaptive immune response. LPS is capable of triggering two 
distinct activation pathways by TLR4: MyD88 mediated pathway, and TRIF mediated 
pathway (Figure 2.2). MyD88 mediated pathway is able to activate the NF-B 
downstream pathway in which pro-inflammatory cytokines are released, namely 
Interleukin-6 (IL-6) and Tumor Necrosis Factor alpha (TNF-) to name a few. These 
cytokines recruit leukocytes towards the area of infection, leading to swelling and 
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increasing blood flow in the affected area [12]. On the other hand, LPS can also trigger 
TRIF mediated pathway, which is in charge of stimulating the release of type I 
interferons, Interferon alpha (INF-) and Interferon beta (INF-). These interferons are 
the molecules responsible for cell-to-cell communication and activation of dendritic cells, 
T cells and B cells in response to the presence of a pathogen [48]. Overall, the interplay 
between MyD88 pathway and TRIF pathway is what determines the toxicity level of 
LPS. 
 In this chapter, I will describe how the presence of LA in JTT was tested by the 
use of LPS removing gel (pmxB). How LA was enriched in the JTT sample and how of a 
novel immunoactive LA-like molecule was identified.  
 
2.2. Results 
2.2.1. Polymyxin B affinity resin depletes the immunostimulatory activity of JTT 
In order to test if LA contributes to the immunostimulatory activity of JTT, we 
first treated the herbal formulation with polymyxin B (pmxB) resin, in which pmxB is 
immobilized on agarose [49]. PmxB is a cationic peptide that binds tightly to the LA 
moiety of LPS through a hydrophobic pocket in which the lipophilic acyl chains can bind 
to, while nitrogen stabilize the negative phosphate charges. A decrease in 
immunostimulatory activity from pmxB treatment would indicate LA is present in the 
JTT sample. Three different samples, namely, untreated JTT (DMSO), mock treated JTT 
(JTT sample that had been passed through streptavidin affinity resin), and pmxB-treated 
JTT, were subjected to a cell-based assay of immunostimulation. In this assay, qRT-PCR 
is employed to quantify the mRNA induction of intercellular adhesion molecule 1 
(ICAM-1), our chosen biomarker of immunostimulation, in THP-1 cells (a human 
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monocytic cell line). The results showed that the induction of ICAM-1 was lowered from 
29 to 12-fold upon pmxB treatment of JTT (Figure 2.3b). The observed result was 
consistent with the hypothesis that LPS/LA contribute to the immunostimulatory activity 
of JTT, although it remained possible that the pmxB-treatment removed 
immunostimulatory factors other than LPS/LA. As it is possible that pmxB binds other 
positively charged phospholipids, we decided to pursue a different approach.  
 
 
Figure 2.3. PmxB effects on JTT immunostimulatory activity. a.  The structure of polymyxin 
B (pmxB) resin, a cyclic peptide that is capable of binding LPS/LA by ionic and hydrophobic 
interactions. b. Activity of JTT upon treatment with pmxB resin. When JTT was treated with 
streptavidin affinity resin (JTT Mock), there was no change in activity. There is almost a 17-fold 
difference in activity between sample with pmxB treatment and untreated sample. THP-1 cells 
were treated for 4h, with DMSO, negative control; JTT (100 µg/mL); JTT Mock (20 µg/mL), 
resin negative control; and JTT PmxB (20 µg/mL). Cells were lysed and RNA was purified using 
RNA kit. RNA was reverse transcribed and diluted. The samples were then analyzed by qRT-
PCR using ICAM-1 probe. Statistical analysis using student’s t-test showed correlation with p < 
0.01  
 
2.2.2. Enrichment of LA from JTT. 
Although the loss of activity in JTT sample after pmxB treatment suggested that 
LPS/LA was present in the herbal mixture. In order to find more evidence for the 
presence of LA, the next step was to enrich LA by using a modified protocol for bacterial 
LA extraction [50] (Figure 2.4a). First, JTT was boiled in water and filtered to remove 
a. b. 
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any insoluble material. The aqueous solution was then cooled, and washed with organic 
solvents to delipidate the sample. LPS would stay in the aqueous layer because of the 
large hydrophilic polysaccharide moiety. The water extract was then acidified (pH 4.5) 
and heated to hydrolyze LPS. The resulting LA, which is much more hydrophobic than 
LPS, was then extracted to the organic layer of the CHCl3/MeOH/H2O 2:2:1.8 (v/v/v/v) 
mixture. To further purify the LA sample, preparatory TLC (CHCl3/MeOH/H2O/NH4OH, 
40:25:4:2 (v/v/v/v)) was performed. The resulting preparatory TLC fractions exhibited 
the Rf values that were consistent with the polarity of typical LAs (Figure 2.4b)  
 
 
Figure 2.4. Purification scheme for Lipid A enrichment. a. The first delipidation step removes 
most lipids while LPSs remain in the aqueous phase. The crude LPSs were transformed to LA by 
acid hydrolysis. LA was enriched in the organic layer. b. TLC profiles of LA-like factors. In the 
condition used (CHCl3/MeOH/H2O/NH4OH, 40:25:4:2, v/v/v/v), LAs typically show up in the Rf 
region highlighted by the red bar (Rf 0.2–0.6). 
 
2.2.3. Activity of enriched LA from JTT. 
The immunostimulatory activity of the obtained fractions was tested by the 
ICAM-1 assay. By comparing the activity of the samples to the DMSO control, we 
observed the highest activity on fractions 3, which coincided with the Rf consistent with 
a. b. 
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the presence of LA (Figure 2.5). Fraction 1 had the lowest activity out of all samples. 
Fractions 2, 4 and 5a were active, with the activity likely coming from LA content. 
Overall, these results strongly suggested that LA was enriched and present in at least 4 
fractions. 
 
Figure 2.5. Immunostimulation by LA-like factors. ICAM-1 qRT-PCR of LA enriched 
fractions of JTT in THP-1 monocytes. THP-1 cells were treated with 5 different fractions (Fr.1 to 
Fr.5) of enriched LA from JTT. All fractions were tested and the most active fraction was found 
to be Fr.3. THP-1 cells were treated with DMSO; JTT (100 µg/ mL); LPS (100 ng/mL); LA-like 
factors (5 µg/mL). The relative quantification (RQ) values were used to compare the samples 
against DMSO control. RQ is the fold-change ratio of samples against DMSO control. All 
samples were run on triplicates under said experimental conditions. 
 
2.2.4. Characterization of active LA fraction by Mass Spectrometry. 
To determine if the LA was indeed found in these fractions, we used mass 
spectrometry (MS) to check for the expected molecular mass. We found m/z for single 
charged and double charged in positive mode that had a molecular formula consistent 
with the backbone of monophosphorilated LA, molecular formulas of C83H145N2O23P 
(Mass: 1568.9976) and C120H217N4O38P (Mass: 2353.4908) (Figure 2.6). More 
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importantly, the m/z was not a perfect match for known LA structures, making it possible 
for a novel LA variant to be present in the herbal mixture. 
 
 
Figure 2.6. Mass spectroscopy of JTT fractions. HRESIMS analysis of LA-like factors 
(Fraction 3 in Figure 2.5). Ions corresponding to two LA-like factors (Cpd 1 and Cpd 2) were 
observed in Fraction 3. Table provides possible LA species based on M/Z ratio matching LA 
structure.  
 
2.3. Discussion 
Up to this point immune modulation of JTT has been attributed to compounds 
originating directly from the herbs, without considering the bacteria present in JTT. As 
JTT consists of 10 herbs, it is likely that total bacteria load is very complex. With this in 
mind, it becomes clear why the isolation of the immunomodulating factor was quite 
complicated. First of all, only a fraction of the total plant biomass can be attributed to 
bacteria; and even a smaller fraction can be attributed to LPS-containing gram-negative 
a. b. 
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bacteria. The amount of expected LPS/LA therefore would be minimal. Thus, it was no 
surprise that LA was not easily detected during HPLC profiling as well as MS.  
Collectively our results strongly indicate LPS/LA is the main immune-stimulatory 
component in JTT. We were able to deplete the activity of JTT by using pmxB resin, 
suggesting LPS/LA was a key component in the activity of the herbal concoction. We 
were also able to enriched LA from JTT, obtaining fractions that possessed LA-like 
immunoactivity. Out of all this fraction, we confirmed the presence of LA in the most 
active one, fraction 3.  
Our group’s results have important implications in experiments dealing with the 
purification of glycolipids and polysaccharides from plants. The potency of LA and LPS 
can be an issue while looking for immunoactive compounds. Incomplete elimination of 
LPS/LA could falsely make other compounds look like they have immune stimulating 
properties. In our case, during our JTT purification the isolated glycolipids and 
phytosterols were suspected to be immunostimulant, even though the minimal amounts of 
LA in the active fraction was the actual cause of most of the activity. Other groups could 
have had the same problem. For example, other group studying JTT identified 
polysaccharides with mitogenic activity [5, 51]. The extraction of this polysaccharide was 
done by hot water extraction, anion exchange column, and eluting through a hydrophobic 
resin. Based on the extraction method they used, one can conclude that there is possibility 
of LA getting included in the sample. This opens the possibility that, without knowing 
about bacteria contribution, minute amounts of LPS were the actual cause of the observed 
polysaccharide activity in other extractions as well. 
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Studies on Yamoa™ (the ground bark of Funtumia elastica) [52] and the tropical 
fruit Acai [53] (Euterpe olearacea) suggest that the immune-boosting activity of those 
plants is due solely to complex carbohydrates, however our data suggest that there may 
be more to this story. For example, the polysaccharides found in Yamoa and Acai had the 
same activity profile as LPS. In both cases, researchers tried to eliminate any possibility 
of LPS by eluting the samples through a column of endotoxin-removal gel. The removal 
of LPS, however, may be partial due to the fact that LPS forms aggregates in water, 
hiding the LA fragment from the gel. We suggest that this might be similar situation as 
with the previously mentioned polysaccharides from JTT. The same way LPS was found 
to be important in the activity of JTT, and the activity of echinacea [22, 24]. These 
findings open up exciting possibilities for the discovery of novel LAs in JTT and other 
medical herbs and for the study of herbs immunostimulatory activity.  
LA’s unique structure made it difficult to isolate ample amounts of the substance. 
During our JTT study, we were able nevertheless to secure enough of the material from 
the most active fraction, Fraction 3 (Figure 2.5) to perform LC/MS. The MS spectra was 
our first direct confirmation that LA was present in JTT (Figure 2.6). Even more 
interesting, the structure of the LA molecule we isolated and began to characterize does 
not match any of the known structures found on public database, suggesting we recovered 
novel immunostimulating compounds. From the proposed molecular formula obtained 
from fraction 3 (monophosphorilated LA), one can infer the structures of the LAs 
observed in the other fractions. Fraction 2 could possibly have longer acyl chains. 
Fraction 4 and 5a, could be diphosphorilated LAs or even partial deacylated [50]. 
Deacylation would be reasonable assumption, because tetraacylated LA is less active than 
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hexaacylated [30]. The fact that most fractions were active suggest that there might be 
many more novel LAs to be found in JTT, which in the future we might be able to 
characterize. Once identified, these LAs could lead to the creation of an immunoadjuvant 
library of LAs.  
Overall, enrichment of LA showed that LA-like factors were present in JTT. The 
fact that multiple factors were present indicates the possibility of JTT contains a wide 
variety of LPSs coming from the same and/or multiple bacteria. Therefore, we can 
surmise that the odds of isolating LA from JTT for further characterization are minimal.  
We resolved that one way to deal with the complexity of JTT and home in on the 
identification of LA of interest was by looking at the individual herbal components and 
investigate the bacteria present in them by metagenomic analysis. The results of this 
analysis will be discussed in Chapter 3.  
 
2.4. Materials and Methods 
Materials. Organic solvents were HPLC grade and were purchased either from 
VWR or Fisher Scientific. Juzen-taiho-to (JTT) formulation was purchased from TCM 
Zone/Honso Pharmaceutical Co. (Nagoya, Japan) as a dried water extract. All reagents 
and supplies for qRT-PCR were purchased from Life Technologies (Grand Island, NY). 
Unless specified otherwise, all other chemicals and reagents were obtained from Fisher 
Scientific and VWR and used without further purification.  
Endotoxin Removal using Detoxi-Gel (polymyxin-B affinity resin). 10 mg of 
JTT powder was dissolved in 2 ml of Millipore water to prepare a stock solution of 
concentration 5 mg/mL. Equal amounts (0.5 mL) of Streptavidin Agarose Resin (Thermo 
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Scientific, Prod. # 20349) and Detoxi-Gel TM Endotoxin Removing Resin (Thermo 
Scientific, Prod. # 20339) were taken in separate Eppendorf tubes. The tubes were 
centrifuged at >10,000 rpm for 1 minute to remove preservative solution from the gels. 
The gels were washed 3 times by adding 700 μL of Millipore water and centrifuging at 
>10,000 rpm for 1 minute to remove residual preservative solutions from the gels. 0.5 ml 
( ~2.5 mg) of JTT stock solution was added to Avidin and Detoxi gels. 0.5 ml (~2.5 mg) 
of JTT stock solution was taken in a fresh Eppendorf tube to serve as a positive control 
for the experiment. 0.5 ml of Millipore water was used as a negative control. The 
Eppendorf tubes were placed in a tube rotator overnight at 4°C. The tubes were 
centrifuged at >10,000 rpm for 1 minute the following day. 400 μL (~2 mg) of the 
supernatants of each of the samples was filtered through a 5 ml syringe filter into pre-
weighed eppendorf tubes. The tubes were dried in the Eppendorf Vacufuge, and weighed 
again. The samples were dissolved in DMSO to achieve a concentration of 0.02 μg/μL 
for THP-1 cell treatment. Final concentration of samples in media used for treatment was 
0.1 μg/mL.  
Enrichment of the LA-like factors from JTT. JTT (10 g) was boiled in 
deionized water (100 mL) for 90 minutes. Insoluble materials were removed by hot 
vacuum filtration. Once cooled, the aqueous solution was placed into a separatory funnel 
with 200 mL of CHCl3/MeOH (1:1 (v/v)). The entire mixture was shaken vigorously and 
then left to stand uncapped for about 20 minutes to allow separation of the organic (org) 
and aq layers. The top hydrophilic layer was mixed with 20x acetate buffer to obtain a 
solution in 1x acetate buffer (pH 4.5). The solution was boiled in an Erlenmeyer flask for 
1 h. and left to cool. The hydrolyzed sample was transferred into a separatory funnel. The 
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LA-like factors were extracted with CHCl3/MeOH (1:1 (v/v)) (100 mL × 2). The extract 
was placed in a round bottomed flask with 100 mL of 1-propanol and dried in vacuo.  
Cell culture of THP-1 monocytes. THP-1 cells were purchased from American 
Type Culture Collection (ATCC). Cells were propagated in RPMI-1640 media containing 
25 mM HEPES and L-glutamine (HyClone), 10%(v/v) fetal bovine serum (Fisher), 
1%(v/v) penicillin, streptomycin and amphotericin B mixture (VWR) and 0.005 mM β- 
mercaptoethanol. Cells were maintained in a 37 °C humidified 5% CO2 incubator.  
ICAM-1 qRT-PCR. THP-1 cells were split on the day before the treatment (0.25 
× 106 cells/well of a 12-well plate). After 24 h, cells were treated with samples or DMSO 
vehicle control for 4 hours in a 37 °C humidified 5% CO2 incubator. RNA purification, 
cDNA synthesis, and qRT-PCR on an Applied Biosystems 7500 Real-Time PCR system 
were carried out as described previously.[8, 54] In the qRT-PCR experiment, pre-
optimized assay for ICAM-1 (Life Technologies Assay Id: Hs00277001_m1) and 
GAPDH endogenous control (Life Technologies Catalog Number: 4352934E) were used. 
The ∆∆CT method was employed to quantify the differential expression of ICAM-1 [54]. 
The raw data were first normalized by the endogenous control (GAPDH) for individual 
samples. Then the relative quantification (RQ) values, i.e. the fold-change ratios, were 
obtained by comparing the normalized data against the DMSO vehicle control.  
Fractionation of the LA-like factors by preparatory TLC. Prior to use, TLC 
plates were washed with methanol in a developing chamber and allowed to dry overnight. 
The sample was dissolved in a small amount of CH2Cl2/MeOH (1:1) and spotted on the 
plates. Plates were developed in CHCl3/MeOH/H2O/NH4OH (40:25:4:2 (v/v/v/v)). 
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Visible bands and the areas in between were scraped off and extracted with 
CH2Cl2/MeOH (1:1).  
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Chapter 3 Bacteria Identification in Angelica Sinensis 
3.1. Introduction  
Bacteria was suspected as the cause of JTT’s immune modulating activity. Upon 
our results, we deemed necessary to determine what species of bacteria, if any, could be 
identified and shown to be present and enriched in the herbal mixture. Enrichment of 
specific kind of bacteria has been shown in the case of the rhizosphere of switchgrass [1] 
and Arabidopsis thaliana [2, 3]. Based on our previous data showing the lack of JTT LA 
endotoxicity, we hypothesized that the LAs from these bacteria would be able to 
stimulate the immune response without triggering inflammation.  
While exploring and deciding on what better method to analyze the JTT microbial 
composition, we concluded that attempting to analyze the whole bacteria make-up from 
JTT was not practical due to their enormous diversity. As stated, JTT is composed of 10 
herbs, 6 of them roots (Peony radix, Astragali radix, Rehmanniae radix, Angelica 
sinensis, Ginseng radix, Glycyrrhizae), 1 bark (Cinnamon bark), 1 fungus (Hoelen) and 2 
stems (Cnidium rhizome, and Atractylodes rhizome). Hence, the bacteria component of 
JTT would most likely be very complex to analyze due to the expected diversity.  It was 
also conceivable that JTT would contain a minuscule amount of the DNA needed for 
sequencing, mainly because the commercial samples are sold as water extract. Taking 
these problems into account, we simplified the study by looking at individual components 
of JTT. As rhizobia bacteria are the most common bacteria found in plants, and they are 
associated with roots, that is where our investigation focused. 
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Our lab was able to  determine that 3 herbs showed considerable activity 
individually (Figure 3.1): Angelica sinensis, Peony Root, and Cinnamon Bark [4]. 
 
 
Figure 3.1. Activities of Individual JTT components. (Takaoka [5]). Activity of 10 JTT 
components were analyzed using THP-1 cells. The samples were prepared by resuspending the 
water extract of the herbs in DMSO. Cells were treated with 100 μg/mL of DMSO solution. 
DMSO was used as a negative control. 
 
Based on the activity analysis of the herbs, LA was most likely present in 
Angelica sinensis and Peony Root, because of the higher possibility of endophyte growth. 
Cinnamon Bark as well showed immunomodulating activity, so it was considered for LA 
enrichment.  
A. sinensis, also known as Dong Quai or “female gingseng”, grows in the 
mountains of Japan, China, and Korea. It is used in traditional Chinese medicine to treat 
osteoarthrosis [6-8], inflammation [9-12] and mild anemia [13] to mention a few 
conditions. Studies suggest that A. sinensis also promotes angiogenesis and osteogenesis 
[6, 7, 14-16]., and more importantly, it possesses immunomodulating activity [17-19] The 
second plant with the highest immune activity, Paeonia lactiflora (Peony root), is native 
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of central and eastern Asia and it is mainly used to diminish allergic reactions [20, 21]. 
The last herb was Cinnamomum cassia (Cinnamon bark). It is found all over the world, 
and it’s a very popular spice as well as a natural treatment for diabetes mellitus [22-24]. 
Importantly for us, extensive studies have shown that Cinnamon is able to modulate the 
innate immune system [22-24]. Between the three herbs, we decided to start 
metagenomic analysis with A. sinensis since it showed the highest activity.  
The investigation of the bacterial community in JTT was done using next 
generation sequencing (NGS). 
 Bacteria communities in plants can be studied by 16S ribosomal RNA gene 
(rDNA) analysis. 16S rDNA amplicon sequencing can be done quickly and inexpensively 
through Next Generation Sequencing (NGS) technology. In addition, numerous studies 
have used NGS for the identification of microorganisms in human’s gut, soil and plants. 
NGS has made it possible to sequence multiple fragments of DNA at the same time and it 
allows scientists to look at DNA from multiple sources, by allowing parallel sequencing 
of DNA. Multiple studies examining microorganism population have taken advantage of 
this simple sequencing method. Thanks to NGS, the ability to sequence has grown 
exponentially, becoming readily accessible [25]. There are different types of NGS, 
pyrosequencing being the most popular initially due to its high consistency to the original 
sequence, however the process was slow and expensive due to the need for multiple 
enzymes. We chose to use Illumina sequencing which is mostly used today for its robust 
and inexpensive sequencing. 
One of the key elements for 16S rRNA gene sequencing is the primer design. 
Primers used in this method need to be specific and to allow to discriminate between 
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similar genes (e.g. 16S from bacteria versus 18S in humans). 16S rDNA (Figure 3.2) is 
found in bacteria and archaea, and it is characterized by having regions of high variability 
that are unique to each species and it is considered as a “barcode” that can be used to 
identify specific bacteria. Primers are designed to target the 9 variable regions that are 
used for phylogenetic classification. 
 
 
Figure 3.2. 16S rRNA gene scheme. Bacteria have 9 variable regions (blue) which serve as a 
barcode for the identification of bacteria. Amplification of those variable regions using qRTPCR 
is used for sequencing. The typical size of 16S rDNA is ~1500bp. 
 
3.2. Results 
3.2.1. Confirmation of LA presence in A. sinensis  
LA presence in A. sinensis was initially tested using PmxB assay, which binds 
and removes LA from the herb solution. Our results show that activity of A. sinensis 
decreased when exposed to pmxB based on the levels of ICAM-1 transcription in THP-1 
upon treatment with the different samples (Figure 3.3). This suggests that LA is present 
in the herbal solution and that its activity was impaired due to the binding affinity of 
pmxB to the glycolipid. We concluded that LA is present and active in A. sinensis.   
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Figure 3.3. ICAM-1 qRT-PCR of A. sinensis treated with polymyxin B. THP-1 cells were 
treated with A. sinensis (AS) sample, AS treated with streptavidin resin (AS Mock), and AS with 
polymyxin B (AS PmxB) all at 5 µg/mL. There was a significant loss in activity on AS PmxB 
compared to Mock. 
 
3.2.2. Primer selection for 16S rDNA sequencing.  
To differentiate the various bacteria found in A. sinensis microbiota, we used 16S 
ribosomal RNA gene (rDNA) sequencing.  
Although the classic approach to characterizing the microbial community in A. 
sinensis was culturing the organisms, sequencing was preferred over culturing because of 
the high possibility of having non-culturable bacteria in the sample. The study had the 
added challenge of a scarce bacteria population present in dry herbs, compared to whole 
plants.  
For our study three different samples of A. sinensis, labeled AS1-3, were used and 
three different batches were chosen to study the correlation between batch variability and 
bacteria population. DNA was extracted and the quality of the extracted DNA was 
checked by 260/280 ratio. As expected, dry herbs had small amounts of DNA, although it 
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was enough for amplification by PCR. A set of three well established 16S rDNA primers 
were used for our metagenomic studies, namely, primer pairs PI (fM1/rC5), P2 
(926F/1392R) and P3 (1114F/1392R). All have been successfully used to amplify and 
sequence 16S rRNA gene in plant samples [26-29]. Specification for coverage, length 
and expected size are on Table 3.1. Primer pairs had an overhang that was necessary to 
create an Illumina library.  
 
Table 3.1. List of primers used for metagenomic analysis. 
Primer Name Sequence 16 locus 
fM1 ccgcgtgnrbgahgaaggyyyt  V3 start 
rC5 taatcctgtttgctccccac  V4 end 
926f actcaaaggaattgacgg V5 start 
1114f gcaacgagcgcaaccc V6 start 
1392r acgggcggtgtgtrc  V8 end 
Primers were paired in the following way: fM1/rC5, 926f/1392r, and 1114f/1392r. The nucleic 
acids were defined as: a (adenine); c (cytosine); g (guanine); t (thymine); n (any nucleotide); r 
(purine); b (any but adenine); h (any but guanine); y (pyrimidine).  
 
Primer pairs for Illumina sequencing were chosen based on the following 
criterion: specificity toward 16S rDNA amplification, amplification of multiple variable 
regions, and amplicon fragment size of 300bp-600bp. Amplicon size requirements are 
due to restrictions by the sequencer as well as for computational analysis. Illumina 
sequencer can only handle short amplicons due to technological limitations. If the 
amplicons are too short, there is no overlapping and joining the end-pair of the amplicons 
would not be possible computationally. After choosing the primers, we tested and 
optimized the reaction (Figure 3.4). One of the parameters we optimized was the 
annealing temperature. Primer annealing in the Illumina protocol called for 55ºC, 
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however, the amplification improved when we modified the temperature to 53-58ºC in 
0.2ºC/sec increments. Optimization of PCR and quality check were necessary because the 
added overhang could potentially have affected the amplification efficiency and increased 
the size of the fragments.  
 
 
Figure 3.4. PCR amplification of 16S rDNA in Angelica sinensis. Agar Gel stained with 
ethidium bromide. Three samples of A. sinensis were tested using three different 16S rDNA 
primer pairs (P1-P3).  The 16S rDNA amplicons were seen at 450, 550, and 400 base pairs (bp) 
for P1, P2, and P3, respectively.  P2 also gave a larger band at 950 bp, which is probably of plant 
origin (mitochondrial/chloroplast DNA).  
 
3.2.3. Metagenomic Analysis  
Library preparation, Illumina sequencing and data analysis was done by the 
Genome Technology Center, at NYU Langone Medical Center. 
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Figure 3.5. Quality score chart of the Illumina reads of the 16S rRNA amplicons from 
Angelica sinensis.  Also, known as Phred quality score. Most reads (72.1%) had the quality score 
of 30 or higher. Quality score of 30 (Q30) means that base call accuracy is 99.9%. Q20 means 
99%. Q10 is 90%. A low Phred quality score would increase the chances of having false-positive 
variants. 
 
Illumina data was analyzed using open source software Quantitative Insight Into 
Microbial Ecology (QIIME) version 1.7 and 1.8 [30]. This software groups multiple 
third-party tools for data analysis and data visualization. Data analysis was done using the 
sequencing data obtained from Illumina (fastq file) and a mapping file, containing the 
information about barcodes used for library preparation, primer sequences and samples 
names. Fastq file and mapping file analyzed on QIIME were first pre processed by 
removing primer and adapter sequences. During the pre processing step, the quality of the 
data was also analyzed (Figure 3.5). The quality of the data was determined to be good, 
with 72% of the reads above Q30 (Base call accuracy 99.9%). For data processing, only 
amplicons >Q25 were considered. The amplicons sequences end-pair were then joined 
and the data was further processed by grouping sequences into operational taxonomic 
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units (OTUs). OTUs are grouped by similarity in sequence, and taxonomy was assigned 
by cross referring the OTUs against GreenGenes Database (Figure 3.6).  
 
 
Figure 3.6. QIIME workflow. This scheme shows how data was analyzed using QIIME. There 
are mainly three processes in which data is analyzed and visualized. Sequencing data was 
processed using mapping file as the source of barcode and primer sequence. Data analysis was 
performed to assign OTU’s using GreenGenes Database as reference. After data analysis, 
mapping file was used to create taxonomy charts. 
 
QIIME analysis revealed that our primers were not as specific as anticipated, as 
they amplified sequences belonging to chloroplasts and mitochondria from plant. 
Specifically, P1 and P2 amplified plant mitochondria and chloroplast DNA, while P3 
provided the most information about the bacterial community present in A. sinensis. The 
information obtained from the P3 amplicons pointed us to Phylum: 21, Class: 59, Order: 
108, Family: 219, Genus: 519 (Figure 3.7a). More specifically we the genera Rahnella, 
Pseudomonas, Erwinia, Bacillus were detected more consistently in all the batches of A. 
sinensis.  
Pseudomonas is a very diverse genus, with pathogenic members, as well as plant 
colonizing bacteria. They can be found in fresh water and soil. The genus Erwinia 
consists mostly of plant pathogenic Gram-negative bacteria. 
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Rahnella is a genus of gram-negative bacteria found in multiple environments, 
such as soil, marshes, freshwater, plants, seeds, food and animals such as snails and 
beetles. Rahnella helps the plants grow by fixing nitrogen, making phosphate more 
soluble, and keeping harmful bacteria away [31]. 
Rahnella was the most abundant genus in all three samples of A. sinensis, 
although the abundance varied from sample to sample (Figure 3.7b). Remarkably, the 
abundance of Rahnella in A. sinensis appeared to be associated with the 
immunostimulatory activity (Figure 3.7b,c). Undoubtedly the results gave us a glimpse 
on the importance of bacteria in the activity of herbal formulations. At present we can 
simply speculate that Rahnella is enriched in A. sinensis. Confirmation would require to 
look at the bacterial population in living plants. Even though more studies are needed to 
further characterize the potential correlation, the data give an insight on potential 
environmental factors that may have a role in the clinical variability of different mixtures 
and provide a possible approach for further investigation. 
 For the purpose of our study, however, the genus Rahnella was identified as the 
perfect candidates for LA extraction. Furthermore, additional sequencing data analysis 
showed that most of the readings were consistent with one particular Rahnella species, 
Rahnella Aquatilis 
 
 46 
 
Figure 3.7. 16S metagenomic analysis of Angelica sinensis. (a) The diversity of bacterial 
community in A. sinensis samples. (b) Bacterial genera identified in the three A. sinensis samples 
(AS1, AS2, and AS3). For each sample, the shown result is the average of three independent 
replicates. Rahnella was the predominant genus in all three A. sinensis samples. Although there 
was a total of 16,263 Illumina reads for Rahnella, all reads were classified as Rahnella aquatilis. 
(c) Immunostimulatory activity of three A. sinensis samples (AS1, AS2, and AS3). JTT (Juzen-
taiho-to, 100 μg/mL), an immune-boosting herbal formulation, was used as the positive control. 
The activity was measured by qRT-PCR of ICAM-1 in THP-1 cells. THP-1 cells were treated 
with samples (5 μg/mL) for four hours. RQ (Relative Quantitation): fold change. 
 
3.3. Discussion 
Our search for specific immunostimulatory components of JTT brought us to the 
identification of the microbial community of one of JTT’s components, Angelica 
sinensis.  More specifically we found that Rahnella aquatilis was the more abundant 
strain in A. sinensis, strongly indicating the species as one of the sources of the 
immunostimulating activity exhibited by JTT. The use of metagenomic analysis to 
identify the bacteria present in the plant was successful, but not without difficulties. The 
primers used were not as specific to bacterial DNA as expected, leading to amplification 
of chloroplast and mitochondria. The genetic material in chloroplast and mitochondria 
closely resembles the one found in bacteria. We were able to reduce the effects of 
chloroplast and mitochondria amplification, by eliminating these OTUs. There are new 
technologies that prevent the amplification of chloroplast and mitochondria called PCR 
blockers, or PNAs. These PNAs (pPNA for chloroplasts and mPNA for mitochondria) 
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have high affinity to chloroplast and mitochondria sequence, preventing their 
amplification by PCR. This might be a good method to prevent the same issues in 
metagenomic of other JTT components. 
Our group was the first to profile the microbial community in immunostimulatory 
herbs. Our findings support the hypothesis that herbs are not directly or solely responsible 
for the immunostimulanting activity, but that the enriched bacteria are important players 
in the beneficial and curative effects in humans. Furthermore, these “herbal probiotics” 
that we believe are key elements in JTT may have a role in other preparations as well. 
More importantly our data highlight the importance of the bacteria symbiotic relationship 
not just for the plants, but for human purposes independent from agriculture. 
The discovery of a role for symbiotic bacteria in the curative effects of medicinal 
herbs is of fundamental importance also for one of the main issue in the medicinal field 
herbal medicine standardization. A known problem in the preparation of herbal 
formulations is the variability between batches. As an example, in our study we tested 3 
different batches of A. sinensis, two from Japan and one from China. Although, all three 
batches showed good levels of activity (Figure 3.1), the ICAM-1 assay resulted in 
consistent differences between the three samples. This suggests that the potency and 
effectiveness of an herbal mixtures is dependent on harvesting location of the herbs, due 
to on the soil and microbial composition as well as the climate conditions. The fact that 
bacteria are important in the activity of these plants shines a light on why locations is so 
important in the potency of the herb. We expect that, in the future, herbal formulations 
would be improved by standardizing the microbiome. 
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Even though we focused our study on A. sinensis, it is important to mention that 
we also worked with the two other JTT components that showed immunostimulating 
activity (Figure 3.1). Peony lactiflora has been recently studied in another immune 
boosting herbal preparation [32] showing potential for probiotic presence. Our attempt at 
LA enrichment in Peony Radix, however, was unsuccessful. We expect bacteria to be 
present in the root, although we were unable to enrich LA. The preparation of Peony root 
in JTT can consist in peeling the roots and boiling for 5 to 10 min, likely eliminating 
most of the bacteria. To test this in the future we might try to enrich a very fresh herbal 
sample, a differently prepared sample, or the plant itself. The third component, cinnamon, 
was difficult to work with due to solubility issues. It showed nevertheless immune-
activity, most likely caused by the fine particles that remained after filtration. We 
unsuccessfully tried to isolate and amplify bacterial DNA from the sample. In retrospect, 
cinnamon bark may not be in direct contact with significant number of bacteria, since 
most bacteria are expected to be in the parts contacting the soil, hence the activity may 
have a different source. 
For our purposes, once we identified the main source of LA in A. sinensis as R. 
aquatilis, we began to think about how to extract and determine the structure of the LA of 
interest. Initially, we anticipated two main difficulties for the isolation of LA from the 
plant. First, not enough material for analysis. Although small quantities of LA are needed 
for MS analysis, much larger quantities would be required for NMR analysis. Second, 
heterogeneity of LA. There is the possibility of having multiple LA isoforms in an 
individual bacterial species [33]. In addition, the structure of LA is dependent on 
temperature [34-36] and host interaction [37, 38]. This means there are possibly multiple 
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LA variants within A. sinensis, which would be too diluted for extraction and structural 
analysis. Thanks to our metagenomic data we could now corvumvent these problems by 
isolating LA directly from bacteria. 
Even though R. aquatilis has been found beneficial as a component of medicinal 
herbs, it has also been linked to infection in immunocompromised patients [39, 40]. 
Unpublished data on R. aquatilis LPS show that it is endotoxic, although is not as toxic as 
E. coli LPS. JTT, on the other hand, lacks any endotoxicity [41]. This opens the 
possibility that factors from the plant that modulate the activity of LPS. This possibility 
will be discussed further in the next chapter. 
 
3.4. Materials and Methods 
DNA extraction from Angelica sinensis. The study examined three samples of 
A. sinensis (dried root) from China (AS1) and Japan (AS2 and AS3). The samples were 
first ground to small (~2-5 mm) pieces. DNA was extracted using MoBio PowerLyzer® 
PowerSoil® DNA Isolation Kit using the manufacture’s protocol, to which minor 
modifications were made. Dry A. sinensis sample (250 mg) was placed in a glass bead 
tube with 500μL of nuclease free water. Hydrated sample was lysed by vortexing in the 
glass-bead tube for 15min. From then, the manufacture’s protocol was followed until the 
final elution step, in which 50μL of solution 6 (from the kit) was used to obtain 
approximately 1.2-1.6 μg of DNA per sample. For each sample, DNA extraction was 
carried out in three independent replicates.  
PCR. The study examined three different primer pairs, namely, P1(fM1, 
rC5)[26],  P2(926f/1392r),[3] and P3(1114f/1392r).[3] Primer sequences are shown 
below. Each primer contained the overhang sequences for Illumina sequencing; the 
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overhang of the forward primers was 5’-tcgtcggcagcgtcagatgtgtataagagacag-3’; the 
reverse overhang was 5’-gtctcgtgggctcggagatgtgtataagagacag-3’. PCR reactions were 
performed with 100 ng of extracted DNA. The PCR reaction mix incorporated the 
following components for a 25µL reaction: 12.5µL KAPA HiFi HotStart ReadyMix (2×) 
(KAPA Biosystems; Catalog # KR0370), 1µL forward primer, 1µL reverse primer, 
required volume for ~100ng of template DNA, and the volume was adjusted to 25µL 
with nuclease free water. The following PCR protocol was used: 95˚C for 3 minutes for 
initial denaturation, followed by 30 cycles of: 95˚C for 30 seconds (denaturation), an 
annealing ramp at 0.2˚C/second from 50-58˚C for 45 seconds, 72˚C for 1 minute 
(extension); the final extension was at 72˚C for 10 minutes. The PCR products were 
cooled to 4˚C. PCR amplicons were analyzed by electrophoresis (2% agarose).  
Illumina sequencing. Bacterial 16S rDNA was amplified with the three primer 
pairs P1 (fM1, rC5) [26], P2 (926f/1392r) [3], and P3 (1114f/1392r) [3], following the 
Illumina 16S Metagenomic Sequencing Library Preparation protocol [42] with the 
following modification: 250 ng of microbial/plant DNA mix was used as template, and 
the following PCR amplification conditions were used: 3 minutes at 95°C initial 
denaturation, followed by 30 cycles of: 30 seconds at 95°C, 15 seconds at 50°C, 10 
seconds at 58°C, and 1 minute at 72°C, followed by a 2 minute final extension at 72°C.  
Libraries were built using the Nextera protocol exactly as described in the Illumina 16S 
Metagenomic Sequencing Library Preparation protocol, pooled, and run on a MiSeq 
using a 600 cycle cartridge, as 2 × 300. 
Data analysis. Microbial community profiling analyses were performed on reads 
from the 2 × 300 Illumina MiSeq sequencing run. After quality analysis of the raw reads 
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(Illumina BaseSpace) and fastq raw sequence file generation (bcl2fastq), the open-source 
software, Quantitative Insights Into Microbial Ecology (QIIME) software versions 1.7 
and 1.8 [43] was used on the NYULMC High Performance Computing cluster. QIIME 
version 1.8 was used to join paired-end reads and de-multiplex barcodes with a Phred 
quality score threshold of >Q25. QIIME version 1.7 was used for the rest of the 
workflow: closed-reference operational taxonomic unit (OTU)-picking process using the 
BLAST algorithm aligning reads against the GREENGENES (gg_otus-13_8-release) 
97_otu database of known 16S bacterial sequences, followed by phylogenetic diversity 
analysis with a default sampling depth of 1000 sequences per sample.  
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Chapter 4 Role of plant material in LPS modulation 
4.1 Introduction  
Plants and bacteria are known to interact in ways that are often beneficial for both 
organisms. Equally important, some of the products of these mutualistic interactions have 
been found to be advantageous to humans as well. One way humans can benefit 
indirectly from these interspecific interactions, is through increase in crop growth rate 
and crop health. A more direct benefit for humans is found in herbal medicine where, as 
we are discovering, bacteria and plant interaction can be fundamental for the production 
of compounds beneficial for human health. For example, it was recently discovered that 
the immune-boosting herbal supplement Echinacea purpurea contained 
lipopolysaccharide (LPS), a known endotoxic glycolipid found in Gram-negative bacteria 
[1]. More importantly, it was found that LPS load directly correlated to macrophage 
activity caused by the herbal supplement [1-3]. Independently, our research suggested 
that bacteria’s Lipid A (LA) is the key component in JTT active fraction, giving the herb 
its immune modulating activity [4]. The low concentration of LA in the sample as well as 
the heterogeneity of the herbal decoction hindered the isolation and structural 
identification of LA. To minimize the heterogeneity problem of the full plant concoction, 
analysis was simplified by focusing on individual herbs. This lead to the analysis of 
individual plant components, finally focusing on Angelica sinensis, which was selected 
due to its high ICAM-1 stimulation on THP-1 cell assay.  
As previously mentioned in Chapter 3, in order to find the source of LPS we 
performed metagenomic analysis on the herb, which revealed that bacteria Rahnella 
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aquatilis was most abundant in A. sinensis samples. Interestingly, the R. aquatilis load 
appeared to correlate with the immune modulating activity of A. sinensis [4]. Our interest 
in Kampo herbal formulations such as A. sinensis and JTT comes from their long tested 
safety, therefore being possible source of novel and safe immunostimulants. Now it is 
suspected that there are beneficial bacteria within the herbs that contributes to the 
immune-boosting activity. We call these bacteria “herbal probiotic,” and we postulated 
that R. aquatilis was the cause of this safe immune stimulating activity of A. sinensis. Our 
finding suggests the importance of herbal probiotics not only in A. sinensis and JTT but 
possibly in other medicinal herbs.  
LPS is a known immune stimulating agent, which can normally lead to sepsis in 
high concentrations [5-7]. R. aquatilis, although not reported as a pathogenic bacteria, 
can be pathogenic in immunocompromised patients [8-10] and newborns [11]. The 
observation of LPS as the main immunostimulatory factor in A. sinensis raises two 
possibilities. (1) LPS of plant-associated bacteria are not toxic. (2) LPS of plant-
associated bacteria are still toxic, but plant compounds attenuate the toxicity. The latter 
possibility is more likely because LPS of R. aquatilis is known to be endotoxic, although 
in-vivo studies show toxicity is lower than the E. coli LPS. 
The activity of LPS with plant glycolipids and phytosterols can be affected by 
factors such as aggregation, caused by the amphiphilic nature of glycolipids, forming 
micelles, liposome or immune stimulating complexes (ISCOMs). Studies have linked the 
size of aggregates to modulation of the immune response [12-14], and it’s also known 
that LPS alone can form aggregates in solution. Based on this information, we 
hypothesize that plant molecules can modulate the aggregation state of LPS, 
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reducing its toxicity. The effect of aggregation and immunostimulation has been 
observed previously by our lab (Figure 4.1). During the study of JTT active fraction, it 
was found that when the fraction was divided into equal part, and resuspended in either 
100% methanol or 90% methanol-water, aggregates formed which modulated the activity 
of the mixture. In this case, the sample treated with 100% methanol formed smaller 
particles which showed higher activity on ICAM-1 assay compared to 90% methanol, the 
later forming bigger aggregates. At the time of this study the presence of LPS on the 
fraction was unknown, and BSSG was the suspected immunostimulant. Now, knowing 
the components at a molecular level can lead to a deeper understanding on how JTT 
works. 
 
 
Figure 4.1. Particle formation by JTT fraction. Samples with the same composition (from JTT 
active fraction) were dissolved in 90%MeOH (sample ‘90%’) and 100%MeOH (sample ‘100%’). 
Solvent was rapidly evaporated and aggregation was characterized by AFM and DLS. (A) The 
‘90%’ sample showed mostly large BSSG aggregates. (B) The ‘100%’ solution mainly composed 
of small nanoparticles. The insets in the AFM images are the height profiles of representative 
particles. The lower DLS panels in (A) and (B) show the particle distributions, which were 
consistent with the AFM results. Figure from Hasson et. al [13] 
 
The idea of particle formation was further supported by another project done in 
our lab (Figure 4.2). In it, a mixture of GluCer and ceramide showed decreased activity 
over  period of 3h [15]. It was determined that the overall activity of the sample 
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diminished over time, while the size of the particles decreased, supporting the idea of 
liposome formation.  
 
 
Figure 4.2. TEM images of GluCer/Cer mixture at t=0 and 3 hours (left) and EDXA 
Netcounts spectra (right): GluCer/Cer was re-constituted in DMSO (1 μg/μl) then diluted in 
Millipore water (final concentration = 5 μg/mL). Two 8 μl of GluCer/Cer mixture was placed on 
a grid, then one 8 μl of 1% sodium phosphotungstate solution was added. The grid was air dried 
before the measurement. Figure from Takaoka (unpublished [15]) 
 
We sought to test our hypothesis by studying mixtures of LPS with phytosteroids 
and glycolipids, and examine their immunostimulatory activity using ICAM-1 qRT-PCR 
assay. The molecular assembly of LPS was studied using dynamic light scattering (DLS) 
and transmission electron microscopy (TEM). We now can potentially recreate the 
original herb’s composition synthetically, getting closer to explaining how JTT works. 
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Another way in which plant components could modulate the toxicity of LPS is by 
decreasing the inflammatory response. Plant glycolipids and phytosterols have similar 
structures to compounds with known anti-inflammatory activity [16-18]. The herbs’ 
richness in anti-inflammatory glycolipids must be important in modulating the 
immunostimulatory activity of the plant as well. Herbal formulations are known to be 
very heterogeneous, and this is a common problem in understanding how herbal medicine 
acts because interaction of multiple components may be what leads to the overall effect 
during treatment. A known example is probenecid and penicillin. Probenecid hinders the 
transport of penicillin by binding and inhibiting organic anion transporters (OATs), 
which are in charge of excreting metabolites [19]. This leads to penicillin lasting longer 
in the blood stream [20, 21]. This effect is called synergistic effect, when a molecule can 
potentiate the effect of another one. There is also an antagonistic effect, in which 
molecules can inhibit the activity of other molecules. One example is the case of 
aminoglycosides (i.e. gentamicin) with penicillin (i.e. piperacillin and carbenecillin). The 
two compounds form an insoluble precipitate when used as a mixture lowering the 
activity of both drugs [22-24]. 
In this chapter, we will discuss how we were able to determine how aggregation 
affected LPS activity, as well as how activity of LPS was further modulated by exposing 
LPS to solvent mixtures in order to change the aggregation state. 
 
4.2. Results 
4.2.1. LPS/LA extraction and ICAM-1 assay standardization. 
In order to successfully test LPS activity using ICAM-1 assay, significant 
quantities of R. aquatilis would need to be cultured and harvested. Instead of extracting 
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LPS for preliminary studies, commercial E. coli LPS was acquired. E. coli LPS was 
diluted to determine the concentration at which change in LPS activity would the greatest 
for ICAM-1 assay. The ideal concentration was found to be 0.1 ng/mL. At this 
concentration, any change in ICAM-1 level would be significant. 
 
 
Figure 4.3. LPS titration. Optimal LPS concentration was determined using THP-1 assay. Five 
samples ranging from 50 ng/mL to 0.1 ng/mL were used and compared to DMSO. Amount of 
DMSO added was 10uL per well. DMSO was used as a negative control. LPS concentration is 
labelled underneath the sample. 
 
The activity of crude LPS from R. aquatilis was examined and compared to E. 
coli LPS. Most studies use the hot phenol - water [25, 26] extraction method for LPS 
extraction. This can be considered the standard method of LPS extraction, and its major 
advantage is that it easily lyses bacterial cells without the use of physical lysis (e.g. lysis 
column or French press). In our case, LPS was extracted using modified standard water - 
phenol method, called tri-reagent extraction [27]. This method was selected because it 
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limited the use of hot phenol, making it easier to perform at room temperature. Tri-
reagent method was used to isolate and hydrolyze LPS to obtain LA for further analysis.  
To determine if LA was successfully isolated from bacteria, THP-1 assay was 
performed on the enriched LA fraction from E. coli (TOP10) and R. aquatilis (ATTC 
33991). LA was also characterized by endotoxicity level, using limulus amebocyte lysate 
(LAL) assay. Concentration of LA samples was dictated by the assumption that crude 
product would have smaller amount of active LA for both cell treatment and LAL assay. 
LAL assay suggested that LA from R. aquatilis is more endotoxic than E. coli LA at the 
same concentration, although studies suggest R. aquatilis LA is less toxic but more 
pyrogenic than E.coli LPS [28]. 
 
 
Figure 4.4. Activity of extracted LA from E. coli and R. aquatilis. ICAM-1 qRT-PCR of LA 
extracts from R. aquatilis and E. coli were compared. THP-1 cells were treated with DMSO, 
negative control; LPS (commercial sample, E. coli LPS, 0.1 ng/mL), positive control; E. Coli 
crude LA extract (5 µg/mL); R. aquatilis crude LA extract (5 µg/mL).  
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Table 4.1. LAL assay results. 
Sample  Concentration (ng/mL) EU/mL (mean±SD) 
E. coli crude LA 4000 0.25±0.06 
R. aquatilis crude LA 4000 1.50±0.15 
E. coli LPS (commercial) 0.8 1.24±0.03 
Presence of LA was detected by using LAL assay, Samples of E. coli crude LA (4 µg/mL)  and R. 
aquatilis crude LA (4 µg/mL) were added to the assay, with the addition of commercial E. coli 
LPS (0.8 ng/mL). Absorbance at 405 nm was recorded and DMSO was used as background. LA 
from R. aquatilis and E. coli was compared. 
 
4.2.2. Mixture effect 
Now that most of the components in the active fraction were identifies, ICAM-1 
assay was performed to test for the activity of glycolipids as single, double or triple 
mixture. But first, we needed to limit the number of component that would be used for 
further analysis. 
Due to complexity of the JTT mixture, we needed to limit the range of glycolipids 
and phytosteroids that would be used for this study. Previously, some glycolipids and 
phytosteroids found by our group were tested using our ICAM-1 assay. Glycolipids and 
phytosteroids as a single or binary mixtures showed no significant immunostimulation 
[15, 29]. We decided to use BSSG, DGDG, MGDG, and ß-GluCer for analysis with LPS. 
One reason was availability, also their suspected anti-inflammatory activity, as well as 
their abundance in the active JTT fraction. The glycolipids/phytosterol and LPS were 
mixed so the final concentration during treatment was 5 µg/mL for the former and 0.1 
ng/mL for the latter.  
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Figure 4.5. Activity of glycolipid mixtures. ICAM-1 qRT-PCR.THP-1 cells were treated with 
DMSO as negative control; LPS (0.1 ng/mL), positive control; BSSG (5 µg/mL); GluCer (5 
µg/mL); DGDG (5 µg/mL); LPS+BSSG (0.1 ng/mL, 5 µg/mL); LPS+GluCer (0.1ng/mL, 5 
µg/mL); LPS+DGDG (0.1 ng/mL, 5 µg/mL); LPS+MGDG (0.1 ng/mL, 5 µg/mL); 
LPS+BSSG+DGDG (0.1 ng/mL, 5 µg/mL, 5 µg/mL); LPS+BSSG+MGDG (0.1 ng/mL, 5 µg/mL, 
5µg/mL). 
 
Mixtures of LPS/DGDG, LPS/MGDG and LPS/GluCer greatly increase the 
upregulation of ICAM-1 compared to LPS alone (Figure 4.5). At the same time, 
LPS/BSSG mixture has a more discrete activity compared to LPS. The addition of BSSG 
to the more active binary mixtures LPS/DGDG and LPS/GluCer dramatically lowered the 
activity of the mixture (LPS/DGDG/BSSG and LPS/DGDG/BSSG).  
Although the activity modulation caused by GluCer, MGDG and DGDG was 
significant, LPS/BSSG mixture was studied in more detailed because BSSG was the most 
predominant component in the active fraction.  
We proceeded to test if change in BSSG concentration would affect LPS. The 
concentration of LPS was kept constant while BSSG was gradually increased from 0.5 
µg/mL to 50 µg/mL. The typical glycolipid concentration during previous experiments 
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was 5 µg/mL, because it reasonable to assume that that concentration related to common 
herbal dosage of during herbal medicine consumption.  
 
 
Figure 4.6. BSSG gradient with LPS. ICAM-1 qRT-PCR.THP-1 cells were treated with DMSO 
as negative control; LPS (0.1ng/mL), positive control; LB which is LPS at a set concentration of 
0.1 ng/mL + BSSG at concentrations ranging from 0.5 to 50 µg/mL. 
 
As it was previously observed, LPS with BSSG mixture at a concentration of 
5µg/mL would decrease ICAM-1 upregulation compared to LPS alone. Interestedly, 
BSSG increased the activity of LPS at 0.5 µg/mL, making it clear that multiple factors 
are at play, and these factors are concentration dependent. One of the factors at play is the 
formation of micelles or liposomes. 
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4.2.3. Molecular assembly as means of immune modulation 
As reported by our lab, molecular assembly is a usual occurrence in the 
identification of plant glycolipid and phytosterols by monocytes and macrophages. A 
known example of particle forming compound is LPS. LPS at different concentrations 
forms distinctive particles in water. Therefore, for studies of LPS in aqueous 
environment, particle formation needs to be considered.  
Dynamic Light scattering (DLS) was used to determine size of particles in 
solution. Molecular assembly is time dependent effect, as observed in the GluCer/Cer 
system [13, 30]. The stability of LPS after 3 h was tested, as well as the effects of time on 
LPS assembly. 
 
  
Figure 4.7. DLS of E. coli LPS. Samples of LPS were suspended in DMSO and added to water. 
Concentration of LPS in solution was 0.1 ng/mL and 1 ng/mL. Multiple scans were averaged. 
Most significant runs are shown. Measurements shown were performed at t =3h. 
 
Table 4.2. Time effects on E. coli LPS particle size. 
 
0h 3h 
[LPS]ng/mL Size avg Pdi avg Size avg Pdi avg 
0.1 408 0.076 991 0.428 
1 368 0.411 234 0.209 
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The ability of BSSG to form nanoparticles was studied as well. BSSG was more 
stable in solution, without showing a significant size change over a 3-hour period., not 
aggregating as in the case of LPS.  
 
 
 
Size avg Pdi avg 
157nm 0.171 
Figure 4.8. BSSG DLS. BSSG solution was resuspended in water to a final concentration of 
5µg/mL Runs at time 0h, 1h and 3h were averaged and plotted.  
 
In the case of BSSG there was no significant change in size over time. Particle 
formation of the mixture of LPS and BSSG was measured as well. After mixing LPS and 
BSSG, we observed a decrease in ICAM-1 activity compared to LPS alone. Extrangely 
enough, the particles formed by the mixture are smaller than any of the starting elements 
in solution (Figure 4.9). This lead us to further study molecular assembly as means of 
immunoactivity modulation. 
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Figure 4.9. Particle formation can modulate LPS activity. (a) ICAM-1 qRT-PCR.THP-1 cells 
were treated with DMSO as negative control; LPS (0.1 ng/mL), positive control; BSSG (5 
µg/mL); LPS+BSSG (LB)  (0.1 ng/mL, 5 µg/mL). (b) Size of glycolipids as determined by DLS. 
Samples were dissolved in DMSO and resuspended in water. 
 
4.2.4. Immune activity modulation by solvent manipulation. 
The amphiphilic characteristic of LPS and BSSG is a key factor in molecular 
assembly. Natural product consumption is mostly done by dissolving these molecules in 
hot water, which would lead to particle formation by amphipathic molecules.  
From previous observations done in our lab [13, 15], it became clear that solvent 
manipulation could be used to modulate the activity of LPS. By resuspending LPS with 
either 90% MeOH or 100% MeOH solution, compared to no resuspension, affected the 
activity of the endotoxin.  
 
a. b. 
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Figure 4.10. Solvent effect on LPS. Water solution of LPS was separated into 3 fractions. 
Solvent was evaporated and samples were resuspended either with MeOH (L100), 90% MeOH 
for (L90), or no solvent (L0). Samples were dried for 3 hours and re-constituted in DMSO. THP-
1 cells were treated with DMSO, negative control; L100 (0.1 ng/mL); L90 (0.1 ng/mL); L0 (0.1 
ng/mL). 
 
Although the difference between LPS in 100% MeOH and 90% MeOH in this 
system was negligible, it was important to check how solvent affected LPS/BSSG 
mixture as well. ICAM-1 qRTPCR was used to test the activity of LPS/BSSG mixture 
resuspended in either 100% MeOH (LB100), and 90% MeOH (LB90) (Figure 4.12a). 
There was a considerable decrease in immunoactivity from exposure to 90% MeOH, 
which can be attributed to size change or surface charge, or both. DLS was used to test 
for size and surface potential differences between LB100 and LB90. The size of the  
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Figure 4.11 Sample preparation scheme. LPS and BSSG were mixed in Methanol, then divided 
into equal parts. Samples were dried, and 100% MeOH was added to one tube, 90% MeOH to 
another, and nothing was added to the third one. Solvent was dried again, and samples were 
labeled as LB100, LB90 and LB0. All samples were resuspended in DMSO and cells were treated 
with 10 µL of solution (LPS 0.1 ng/mL; BSSG 5 µg/mL). Same scheme applies to preparation of 
LPS samples. 
 
 
Figure 4.12. Solvent effect on LPS/BSSG. qRT-PCR analysis as well as DLS analysis of 
LPS/BSSG in 100% methanol and 90% methanol was performed. a. ICAM-1 expression of 
LPS/BSSG (LB) samples after 4h treatment. Samples were prepared by dividing equally 
LPS/BSSG freshly prepared mixture, evaporated solvent, and resuspended in MeOH (LB100), 
and 90%.MeOH (LB90). Samples were again dried, and re-constituted in DMSO. Cells were 
treated with DMSO, negative control; LPS (0.1 ng/mL), positive control; LB100 (0.1 ng/mL LPS, 
5 μg/mL BSSG); LB90 (0.1 ng/mL LPS, 5 μg/mL BSSG). b. Representative DLS spectrum of 
LB90 and LB100 at t=2.5h. Peaks are labelled as peak 1 (91nm for LB100; 105nm for LB90) and 
peak 2 (~5000nm). 
a. b. 
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Figure 4.13. TEM of LPS/BSSG. Sample of LPS/BSSG in MeOH was re-constituted in DMSO 
(1 μg/μl) then diluted in Millipore water (final concentration = 5 μg/mL). Two 8 μl of LPS/BSSG 
mixture was placed on a grid, then one 8 μl of 1% sodium phosphotungstate solution was added. 
The grid was air dried before the measurement. 
 
In order to determine how solvent manipulation affected the assembly of 
LPS/BSSG particles in water, DLS was used. Size of particles and surface are two of 
multiple factors that can affect the immunostimulatory activity of the mixture. Because 
particles were suspected to be time sensitive, DLS was also used to check for particles 
aggregation (Figure 4.12b). The parameters obtained by DLS were Size average, 
Polydispersion index (pdi), and Peaks of interest, in this case only 2 of them. Size 
average values are equated to size, but it does not correlate to the real sizes we are seeing 
in, for example, LB90 (Figure 4.14a). Although interesting, that’s not the complete 
picture. Pdi describes how homogenous the sample are, for example if there is only 
particles of a single size (monodisperse) or multiple sizes (polydisperse). Values of for 
LB90 and LB100 within the range of 0.1-0.2 suggest a narrow size distribution. 
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Interestingly, pdi for LB90 oscilates from 0.05 to 0.2, suggesting difference in 
distribution over time (Figure 4.14b). From pdi values we suspected possible 
aggregation, so to further understand the difference in distribution, we looked at isolated 
sizes. LB90 and LB100 mainly got distributed between 2 sizes, described by Peak 1(90-
110nm) and Peak 2 (~5000nm). Peak 1 for LB90 and LB100 is constant throughout ~3h, 
with the same size of 120nm for both. The main difference is at Peak 2, which represent 
bigger particle formation. During the ~3h study, LB90 had bigger particles.  
By correlating activity with size, we determined that there is a small but 
significant difference between LB90 and LB100. Over time, the size increased. 
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Figure 4.14 DLS of LPS/BSSG over time. LPS/BSSG resuspended in MeOH (LB100, orange) 
and LPS/BSSG resuspended in 90% MeOH (LB90, blue) were analyzed by DLS. DLS was run 
over a period of ~3h at room temperature. Samples were prepared by adding 10µL of either 100% 
or 90% in 1mL of water, to a final concentration of LPS (0.1ng/mL)+BSSG(5µg/mL). a. Size 
average. It describes the average size of the particles over time. It is an average of all particle 
sizes in the sample. b. Polydispersion Index. Describes if different particles sizes are present 
within the sample. Homogeneous size particle would have a small PDI (0.01-0.1, monodisperse) 
a. 
b. 
c. 
d. 
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and heterogeneous collection of particles would have large PDI (>0.7, polydisperse). c. Peak 1. 
Describes one of the particle present in the sample. Peak 1 is usually the most prevalent. d. Peak 
2. Describes the second particles present in the sample. Peak 2 represents the second most 
prevalent particle. 
 
Effect of preparation in surface polarity. Aggregation in LB90 was tested by 
measuring surface polarity of the particles using Zeta potential. LB90 had a surface 
potential >-30mV, which is the characteristic of incipient stability. Similarly, LB100 
particles also had a surface potential >-30mV, but in this case the surface becomes more 
negative over time, reducing the change of aggregation. 
 
Table 4.3 Zeta potential. 
 Zeta potential 
Sample 0h 1h 3h 
LB90 -20.5±0.9mV -22.0±0.9mV -20.7±0.6mV* 
LB100 -20.5±0.7mV -24.3±1.3mV -26.7±1.8mV* 
Data was collected for samples LB90 and LB100 at 0, 1 and 3 hours.  All readings done at 25ºC. 
*The difference between these samples was p < 0.05. 
 
4.3. Discussion 
In our study, we showed that the addition of plant glycolipids modulates the 
activity of LPS. The formation of particles and aggregates greatly affected the activity of 
LPS. This discovery focused our studies on size-activity relationship. The instability of 
liposomes and the short lifespan made this study challenging. Particles formed by LPS 
were quite stable, with an average size of 1000 nm at a concentration of 0.1 ng/mL. On 
the other hand, LPS can also form bigger particles when concentrated to 1 ng/mL. Even 
though DLS on LPS at higher concentration shows a large distribution at ~300 nm 
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(Figure 4.7), most LPS molecules are likely part on the big particles at ~5000 nm. It 
would be difficult to study the effect of LPS on any system without considering aggregate 
formation and bimodal distribution. On the other hand, BSSG formed stable particles 
with a size of ~157 nm at a higher concentration compared to LPS (5 µg/mL).  
Particle formation was suspected as the cause of the modulation effect of plant 
components with of LPS due to the previous studies done by our lab (Figure 4.1). 
Formation of nanoparticles can lead to immunomodulation by activating different kinds 
of immune cells, by changing uptake mechanisms [31] or by increasing the glycolipid 
surface exposure [32]. When LPS was combined with BSSG, the particles formed were 
closer to the size of BSSG by itself. It makes sense due to the fact that, the molecular 
ratio of LPS/BSSG is 1/50,000. Therefore, BSSG modulated the activity of LPS by 
decreasing the size of LPS particles from 1000 nm to 120 nm. 
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Figure 4.15. Particle uptake. Particles can be uptaken by monocytes and macrophages 
commonly in 2 ways, pinocytosis and phagocytosis. a. Pinocytosis is used by the cell while 
absorbing liquids and small lipid particles. b. Receptor mediated endocytosis is specific and 
consumes energy. Usually receptor mediated endocytosis is used during the uptake of larger 
particles. 
 
BSSG modulation of LPS toxicity can also be at cellular level. BSSG is a 
phytosterol, ubiquitous part of plant membranes found in multiple plant extracts and 
believed to possess anticancer activity [33, 34]. Phytosterols have been also used to lower 
cholesterol levels in patients. In a more recent experiment, it was found that mice 
pretreated with β-sitosterol had lower inflammatory cytokines after induced colitis [35], 
although no activity was observed in other mice studies [36].  
a       b 
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We tried to further modulate the effects of LPS by trying to change the 
aggregation state of LPS/BSSG particles using different solvents. We found that when 
LB was prepared with either 100% MeOH or 90% MeOH, it showed a distinct difference 
in ICAM-1 upregulation, being the case of the sample LB100 more active than LB90. 
Very interesting effect because the ability of solvent to change the effects of LPS have 
never been studied before. One of the main effects of the solvent was to change the size 
of the particles in as well as changing their stability in aqueous environment. LB90 was 
found to have an overall larger Z-average, meaning that the particles formed were bigger. 
The size increase can be described as aggregation effect caused by the polarity of the 
particle membrane (Figure 4.15). Even though LB100 and LB90 have particles with 
120nm diameter, LB90 most likely was able to form less of them, because bigger 
particles can sequester a large quantity of phytosterols and LPS.  
In order to explain the effects of the solvent, we would have to consider 
interactions at the molecular level. Rearrangement after evaporation of the remaining 
water can explain why 90% methanol causes the formation of more unstable particles. As 
the solvent evaporates, the glycolipids polar head group might get buried within the 
nanoparticle, diminishing the electrostatic repulsion and favoring more hydrophobic 
interactions in the aqueous environment. Based on this assumption, the more exposed 
hydrophobic core of LPS would be more readily identified by TLRs, but the spatial 
configuration of the acyl chains in the nanoparticle prevents the recognition.  
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Figure 4.16 Particle formation scheme. Proposed particle formation of LPS and BSSG in 100% 
MeOH and 90% MeOH. a. In the case of 90% MeOH, evaporation would concentrate water until 
at the very end only water remains. The polar portion of the molecules (glucose and 
polysaccharide) would be facing the solvent in this case. Upon further evaporation there is a 
chance that the polar heads would come together and form other kind of particle. b. In the case of 
100% MeOH, LPS and BSSG would form a layer on top of the solvent, in which the hydrophobic 
portion of the molecules (acyl chains) would be contacting the solvent. Further evaporation would 
lead a layer of glycolipids with acyl chains facing the walls of the tubes. c. LB90 in water. 
Formation of more hydrophobic particles is expected, causing aggregation into bigger particles. d. 
a             b 
c             d 
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LB100 in water. More stable particles are formed because of presence of hydrophilic groups 
facing the polar solvent.  
 
There is also the effect of aggregation. Polydispersion index (PDI) gives us an 
idea on how much distribution of particles there is in the solvent. In the case 90% 
methanol, pdi is unstable, suggesting aggregation over time. To understand why the 
particles aggregate, we need to consider Zeta potential. Zeta-potential considers the 
charge of the particle surface, and if there charge is close to zero, that means that they 
particles can’t repel each other, forming larger aggregates. In the case of LB90, zeta 
potential approaches zero over a 3h period. Interestingly enough, the fact that LB100 zeta 
potential becomes more negative over time, suggests that the aggregates become more 
stable.  
There are examples of plant components being part of immunemodulating 
particles. As an example, Quillaia saponin with cholesterol and other phospholipids can 
form immune stimulating complexes (ISCOMs). ISCOMs are used to stimulate immune 
response without triggering the inflammation making it an adjuvant. With this idea in 
mind, this finding can open new research opportunities, such as the development of LPS-
based adjuvant formulations with plant metabolites (analogous to ISCOMs). It can also 
lead to strategies to prevent/treat acute and chronic endotoxemia. 
Overall, we concluded that BSSG modulates the activity of LPS affecting the 
aggregation state of LPS. This modulation can be further tuned by solvent manipulation. 
As expected, the size as well as arrangement on nanoparticles are important factors to 
consider during preparation of glycolipid mixtures. Size as well as surface polarity would 
affect APCs recognition as well as the uptake of particles. Depending on the solvent used, 
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the type of mixing and the use of sonication can dramatically alter the outcome. The size 
difference as well as stability of nanoparticles formed in tandem with BSSG opens a new 
chapter in immunomodulation, in this case by using solvent to change the molecular 
rearrangement.  
 
4.4. Materials and Methods 
Materials. Glucocerebrocide (Soy 98%), digalactosyldiacylglycerol, and 
monogalactosyldiacylgycerol, were purchased from Avanti Polar Lipids Inc. E. coli LPS, 
Nutrient broth medium, and Pierce LAL Chromogenic Endotoxin Quantitation Kit were 
purchased from Life Technologies. E. coli TOP10 was provided by Loayza’s Lab, from 
the biology department at Hunter College. R. aquatilis 33991 was obtained directly from 
ATCC. BSSG was synthetized with the help of Dr. Steward Bachan. Organic solvents 
were HPLC grade and were purchased either from VWR or Fisher Scientific.  
Bacterial strains and growth conditions. E. coli (TOP 10) and R. aquatilis 
(ATCC 33991) were grown on Nutrient broth medium (BD cat 234000). E. coli were 
grown at 37ºC in shaker overnight, while R. aquatilis were grown at room temperature 
overnight. Bacteria were centrifuged, and pellets were used for LA extraction. 
Lipid A isolation using TRIzol reagent. Bacteria pellets (~10 mg) were 
resuspended in TRIzol reagent (200 µL). The bacteria suspension was incubated at room 
temperature for 15 min. The mixture was then washed with chloroform (200 µL) and two 
layers formed. The tube was vortexed for 1 min, mixing the solution vigorously. The 
mixture was left for 10 min at room temperature. The mixture was centrifuged 10 min at 
12000g. The two phases appeared again, which were separated using a glass pipette. The 
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organic layer was places in a clean 1.5 mL test tube, and washes with extra 100 µL of 
chloroform two times. All the aqueous fractions were combined and acidified to a pH 4, 
using acetic acid/sodium acetate buffer. The mixture was then placed on an oil bath at 
100ºC for 2h. Hydrolysis was checked over time, using TLC. After hydrolysis, the 
solution was transferred to a 1.5 mL Eppendorf tube. Tubes were centrifuged for 10 min 
at 2000g, and liquid was decanted carefully. Small pellet was then washed with ethanol 
(500 µL), centrifuged again for 10 min at 2000g, and solvent was decanted. Tube was 
then placed in a high vacuum pump until dry. 
LAL Endotoxicity Assay. Assay was performed exactly as suggested by Pierce 
LAL Chromogenic Endotoxin Quantitation Kit protocol. Test was performed on a 96well 
plate. Samples were dissolved in DMSO, then added to the well with Millipore water to a 
concentration of 4 µg/mL. Absorbance was detected using the Powerwave HT Microplate 
Spectrophotometer.  
Dynamic Light Scattering. Sample was dissolved in DMSO to the following 
concentrations: LPS (0.02ng/µL), BSSG (1µg/µL). 5 uL of the sample were then added to 
1mL of Millipore water on a DSL cuvette.  Zetasizer Nano ZS. For general size 
measurement, and average of 12 scans per run were repeated at least 5 times. All 
measurements were done at room temperature. Results were analyzed and averaged using 
Zetasizer Nano software. In the case of 3h studies, and average of 12 scans were 
performed during ~75 scans. 
Zeta potential. Sample was dissolved in DMSO to the following concentrations: 
LPS (0.02 ng/µL), BSSG (1 µg/µL). 5 uL of the sample were then added to 1 mL of 
Millipore water, then poured on a folded capillary cells. Capillary cell was filled with 
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solution avoiding air bubbles. Zetasizer Nano ZS was used to measure Zeta potential 
values. 12 scans per run were repeated at least 5 times, at different time points (0h, 1h, 
3h). Zetasizer Nano software was used to analyze data. 
Transmission Electron Microscopy. Sample was dissolved in DMSO to the 
following concentrations: LPS (0.02 ng/µL), BSSG (1 µg/µL). Measurements were 
performed at 200 kV on a JEM 2100 (jeol). 8 µL of sample were added to a 300-mesh 
silicon monoxide coated copper grid, (TED Pella Inc., Redding, California, USA). Two 
8-μl drops of 1% aqueous solution of sodium phosphotungstate (stain) were added and 
finally an 8 μl drop of deionized water. The grid was allowed to dry for 1 min under 
protective cover. Excess water was removed using filter paper.  
 
4.5. References 
1. Tamta, H., et al., Variability in in vitro macrophage activation by commercially 
diverse bulk echinacea plant material is predominantly due to bacterial 
lipoproteins and lipopolysaccharides. J Agric Food Chem, 2008. 56(22): p. 
10552-6. 
2. Pugh, N.D., C.R. Jackson, and D.S. Pasco, Total bacterial load within Echinacea 
purpurea, determined using a new PCR-based quantification method, is 
correlated with LPS levels and in vitro macrophage activity. Planta Med, 2013. 
79(1): p. 9-14. 
3. Sharma, S.M., et al., Bactericidal and anti-inflammatory properties of a 
standardized Echinacea extract (Echinaforce): dual actions against respiratory 
bacteria. Phytomedicine, 2010. 17(8-9): p. 563-8. 
4. Montenegro, D., et al., Uncovering potential 'herbal probiotics' in Juzen-taiho-to 
through the study of associated bacterial populations. Bioorg Med Chem Lett, 
2015. 25(3): p. 466-9. 
5. Martin, G.S., et al., The epidemiology of sepsis in the United States from 1979 
through 2000. N Engl J Med, 2003. 348(16): p. 1546-54. 
6. Morrison, D.C. and J.L. Ryan, Endotoxins and disease mechanisms. Annu Rev 
Med, 1987. 38: p. 417-32. 
7. Bone, R.C., Sepsis, the sepsis syndrome, multi-organ failure: a plea for 
comparable definitions. Ann Intern Med, 1991. 114(4): p. 332-3. 
8. Gaitan, J.I. and M.S. Bronze, Infection caused by Rahnella aquatilis. Am J Med 
Sci, 2010. 339(6): p. 577-9. 
 81 
9. Martins, W., et al., Co-transmission of Rahnella aquatilis between hospitalized 
patients. Braz J Infect Dis, 2015. 19(6): p. 648-50. 
10. Tash, K., Rahnella aquatilis bacteremia from a suspected urinary source. J Clin 
Microbiol, 2005. 43(5): p. 2526-8. 
11. Kuzdan, C., et al., Rahnella aquatilis Sepsis in a Premature Newborn. Case Rep 
Pediatr, 2015. 2015: p. 860671. 
12. Brewer, J.M., et al., Lipid vesicle size determines the Th1 or Th2 response to 
entrapped antigen. J Immunol, 1998. 161(8): p. 4000-7. 
13. Hasson, T.H., et al., Immunostimulatory lipid nanoparticles from herbal medicine. 
Chem Biol Drug Des, 2014. 83(4): p. 493-7. 
14. Lee, I.A., et al., Morphological and immunological characterization of 
immunostimulatory complexes based on glycoglycerolipids from Laminaria 
japonica. Acta Biochimica Polonica, 2004. 51(1): p. 263-272. 
15. Takaoka, A., Identification and Mechanistic Study of Immunostimulatory Lipids 
in Juzen-Taiho-To, in Chemistry. 2012, CUNY Graduate Center: New York. 
16. te Velde, A.A., et al., Effects of Dietary Plant Sterols and Stanol Esters with Low- 
and High-Fat Diets in Chronic and Acute Models for Experimental Colitis. 
Nutrients, 2015. 7(10): p. 8518-31. 
17. Shiota, A., et al., Protective effects of glycoglycerolipids extracted from spinach 
on 5-fluorouracil induced intestinal mucosal injury. J Med Invest, 2010. 57(3-4): 
p. 314-20. 
18. Yeom, M., et al., Glucosylceramide attenuates the inflammatory mediator 
expression in lipopolysaccharide-stimulated RAW264.7 cells. Nutr Res, 2015. 
35(3): p. 241-50. 
19. Emami Riedmaier, A., et al., Organic anion transporters and their implications in 
pharmacotherapy. Pharmacol Rev, 2012. 64(3): p. 421-49. 
20. Goh, B.T., et al., Penicillin concentrations in serum and cerebrospinal fluid after 
intramuscular injection of aqueous procaine penicillin 0.6 MU with and without 
probenecid. Br J Vener Dis, 1984. 60(6): p. 371-3. 
21. Jensen, P.E., S.A. Kvorning, and K. Norredam, Probenecid as an Adjuvant in the 
Treatment of Gonorrhoea with Penicillin. Br J Vener Dis, 1963. 39: p. 238-40. 
22. Thompson, M.I., et al., Gentamicin inactivation by piperacillin or carbenicillin in 
patients with end-stage renal disease. Antimicrob Agents Chemother, 1982. 
21(2): p. 268-73. 
23. Viollier, A.F., et al., Comparative pharmacokinetics and serum bactericidal 
activity of mezlocillin, ticarcillin and piperacillin, with and without gentamicin. J 
Antimicrob Chemother, 1985. 15(5): p. 597-606. 
24. Trissel, L.A. and J.F. Martinez, Compatibility of piperacillin sodium plus 
tazobactam with selected drugs during simulated Y-site injection. Am J Hosp 
Pharm, 1994. 51(5): p. 672-8. 
25. El Hamidi, A., et al., Microextraction of bacterial lipid A: easy and rapid method 
for mass spectrometric characterization. J Lipid Res, 2005. 46(8): p. 1773-8. 
26. Rezania, S., et al., Extraction, Purification and Characterization of 
Lipopolysaccharide from Escherichia coli and Salmonella typhi. Avicenna J Med 
Biotechnol, 2011. 3(1): p. 3-9. 
 82 
27. Yi, E.C. and M. Hackett, Rapid isolation method for lipopolysaccharide and lipid 
A from gram-negative bacteria. Analyst, 2000. 125(4): p. 651-6. 
28. Varbranets, L.D., et al., Characterization of the lipopolysaccharide from Rahnella 
aquatilis 1-95. Mikrobiologiia, 2005. 74(4): p. 466-74. 
29. Hasson, T.H., Isolation and Characterization of Immunomodulatory Compounds 
from Juzen-Taiho-To: Novel Understanding of Phytosteryl Glucosides Nano-
Aggregates and Synergism, in Chemistry. 2009, City University of New York: 
New York. 
30. Takaoka, A., et al., Biomarker-guided screening of Juzen-taiho-to, an oriental 
herbal formulation for immunostimulation. Planta Med, 2014. 80(4): p. 283-9. 
31. Yu, S.S., et al., Size- and charge-dependent non-specific uptake of PEGylated 
nanoparticles by macrophages. Int J Nanomedicine, 2012. 7: p. 799-813. 
32. Maitani, Y., et al., Modified ethanol injection method for liposome containing 
beta-sitosterol beta-D-glucoside. J Liposome Res, 2001. 11(1): p. 115-25. 
33. Bouic, P.J. and J.H. Lamprecht, Plant sterols and sterolins: a review of their 
immune-modulating properties. Altern Med Rev, 1999. 4(3): p. 170-7. 
34. Dolai, N., et al., Apoptogenic effects of beta-sitosterol glucoside from Castanopsis 
indica leaves. Nat Prod Res, 2016. 30(4): p. 482-5. 
35. Lee, I.A., E.J. Kim, and D.H. Kim, Inhibitory effect of beta-sitosterol on TNBS-
induced colitis in mice. Planta Med, 2012. 78(9): p. 896-8. 
36. Villasenor, I.M., et al., Bioactivity studies on beta-sitosterol and its glucoside. 
Phytother Res, 2002. 16(5): p. 417-21. 
 
 
 83 
Chapter 5 Current studies and Future directions  
5.1. Introduction  
The presence of LPS in well-known immunostimulatory plants showcase the need 
for more understanding of the bacteria in certain plants. LPS is still the most potent 
immunostimulant available, and it has been utilized in adjuvant formulation, such as 
complete Freund’s adjuvant (CFA). CFA consists on lysed mycobacteria with emulsified 
oil. Even thou CFA is known to be quite harmful, it is still used in animals because it 
consistently produces high titers of multiple antibodies. This consistency is important in 
immunological studies. 
Safety of LPS was the main question raised by our finding in the previous 
chapter, but it was not completely answered. It was found that LPS immunological 
activity can be decreased by the addition of plant compounds. Decreasing cell activation 
does not mean the same as making LPS safe. An adjuvant should still be able to activate 
APC cells. Unlike CFA, a safe derivative of LPS is monophosphoryl lipid A (MPL). The 
lack of endotoxicity from MPL is linked to a TRIF pathway bias compared to MyD88 
pathway.  
The activation of different pathways by LPS is dependent on the binding of LA. 
There are LA that bind but do not activate TLR4, binds and activates both MyD88 and 
TRIF pathways and finally binding which activates only TRIF pathways. Examples are 
showed in Figure 5.1 
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Figure 5.1. Activation of MyD88 and TRIF pathways. Different Lipid A structures would 
interact differently with TLR4. The interaction will either cause no signal, such as the case of 
Lipid IVa, activation of both signal cascades such as the case of E. coli Lipid A, or signaling 
through TRIF pathway, such as the case of MPL. 
 
TLR4 would trigger one of two pathways, all depending on the structure and the 
binding of the LA portion. In the case of Lipid IVa, it is an antagonist, binding without 
triggering TLR4. On the other hand, E. coli LA triggers TLR4 so both MyD88 and TRIF 
pathways are active. This leads in the end to the activation of the immune response as 
well as a strong inflammation response. This is why E. coli LA can cause sepsis. The last 
example would be MPL, which is able to bind to TLR4 and trigger mostly TRIF 
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pathway. This causes the activation of the immune response without the harmful effects 
of inflammation. This is how adjuvant activity is achieved. 
 The endotoxicity of LPS therefore is dependent on the structure of Lipid A. As 
previously mentioned, R. aquatilis LPS proved to be endotoxic in LAL assay, even more 
endotoxic than E. Coli. But this was extracted from R. aquatilis grown in agar, not in the 
soil or close to the roots of the plants. Therefore, we need to understand a lot more about 
bacteria and their growth in plants. 
Bacteria are unicellular microorganisms, invisible to the human eye but found 
everywhere. They can live in all different environments such as soil, deep underwater, 
inside animals as well as inside plants. The characteristic that makes bacteria ubiquitous 
is their ability to adapt. They are extremely resilient; for example, they can adapt to 
changing environmental conditions by interacting with each other and forming biofilms. 
It has been calculated that up to 50 million bacteria can be found on 1 gram of soil, and 1 
million would be found on 1mL of seawater [1].  
Generally, people associate the relationship of bacteria with humans to disease 
and infection. As reported on 2013, at least 2 million people were seriously infected by 
antibiotic resistant bacteria in the US which resulted in the death of at least 23,000 people 
a year [2]. In addition, harmful bacteria can cause food poisoning [3, 4]. Food poisoning 
can be caused by parasites and viruses as well, but bacteria are the most common cause 
of infection.  However, bacteria can be beneficial and valuable to humans as well. For 
example, bacteria are used in the fermentation process of milk products such as yogurt, 
and butter. Cheese and probiotics have been studied and found effective in the treatment 
of gastrointestinal diseases.  
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Bacteria can be found on the skin, mouth and gut of humans, in fact there may be 
as many bacteria as human cells in our body [5].These bacteria are not identified as 
pathogens by our immune system, this allows them to live within mammals and they has 
been determined that they are in charge of keeping harmful bacteria at bay in our 
digestive system as well as maintaining homeostasis [6-8]. Some studies have linked gut 
microbiota to food digestion, health, and diabetes [9-11] as well being linked to obesity 
and bowel inflammation [12-14]. 
In humans, bacteria trigger the innate immunity by interacting with mononuclear 
phagocyte system (MPS) cells, such as macrophages and monocytic cells. These cells 
identify patterns on the bacteria surface like flagella, peptidoglycans and other membrane 
components. LPS, a component of gram negative bacteria membrane, is one of the most 
potent and well-studied pathogen associated molecular patterns (PAMP) [15-18] ever 
found. Even though LPS is known for its pathogenicity, structural modifications in the 
molecule can lead to a mild immune response, or even to a lack of response. For 
example, it has been observed that gut bacteria activate NK cells, stimulating the 
clearance of harmful gut bacteria [19, 20]. Improvement in sequencing techniques have 
brought more interest to the gut microbiota composition and effects [21-23] as well as 
soil and plants bacteria.  
The same fundamental symbiotic relationship seen between bacteria and humans 
can be translated to bacteria and plants symbiosis. There are bacteria that live within the 
roots of plants are called endophytes. There are also bacteria that is found on the 
rhizosphere, which is the soil closely associated to the roots. It is known that endophytes 
are necessary for the well-being of plants in general. They are important for nitrogen 
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fixation in legumes, and have a role in protecting the roots from harmful bacteria and 
fungi by secreting antibiotic [24, 25]. Although the importance of the functions of 
bacteria in plants is understood, more research is needed to decipher how bacteria are 
selectively enriched and be allowed to grow in plants.  
 
5.2 Current and future studies. 
LPS activity is modulated by plant glycolipid, such as BSSG, but now we need to 
ask the next question: Can phytosterols and plant glycolipids decrease not only the total 
activity of LPS, but decrease LPS endotoxicity? JTT is known to activate the immune 
response, without being endotoxic. The mixture of LPS and BSSG might not be just a 
weaken the endotoxin, but might be an active adjuvant with minimized toxicity. 
In order to answer this question; we can propose to: 
Study the effects of JTT components on R. aquatilis LPS. Although unlikely, 
it’s possible that R. aquatilis grown while in contact with JTT components can make LPS 
nontoxic but active. The enrichment could be the key factor in making LPS that is safe, 
by excluding more harmful bacteria and allowing safe to thrive. Also, we might need to 
replicate the environment in which R. aquatilis is grown naturally. Most likely, it grows 
at a different pH due to the soil as well as more dry environment.  
Determine how plant material affects MyD88/TRIF bias. ICAM-1 activation 
can give us very limited information about the activity of the tested compounds. Our 
assay was developed in order to test the immunostimulating effects of JTT. Cells had a 
very similar gene profile after treatment with LPS and JTT. The main difference was in 
the proinflammatory genes were not upregulated in the case of JTT. The problem is that 
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we expect both compounds, LPS and JTT, to upregulate ICAM-1. In order to determine 
which pathway has been activated by LPS and plant compound mixture, we need to look 
at different genes[26-29]. Table 5.1 describe some of the options. 
 
Table 5.1 Genes linked to MyD88 and TRIF signaling [27-29].  
MyD88 TRIF 
INF- MCP-1 
IL-6 CCL5 
COX-2 IL-10 
Serpine 1  
CXCL1  
 
We tried to study the pathways bias using three different probes: IL-6, COX-2 and 
CCL5. Probes for IL-6 and COX-2, both for MyD88 pathway, were consistently 
expressed in our assay. The problem in our case was to find a probe for TRIF pathway. 
The problem was that THP-1 cells have a low basal level of CCL5, the probe that we 
decided to use to check TRIF bias. Consequently, we needed to study the immune active 
effects of LPS and BSSG in other cells, such as macrophages derived from THP-1 cells. 
These macrophages can be obtained by using phorbol 12-myristate 13-acetate (PMA)[30, 
31]. Although these cells had increased level of CCL5, they were less sensitive to LPS. 
Studies with LPS at higher concentrations is currently being perfomed.  
There are other effects of LPS and BSSG worth styding. For example, adjuvants 
are also known to activate different T cells. While adjuvants activate Th2 cells, other 
immunostimulant activate Th1 cells. Th1 cells more linked to inflammation.  
These studies could one day decipher the complexity of herbal mixtures such as 
JTT. 
 
 89 
References 
1. Whitman, W.B., D.C. Coleman, and W.J. Wiebe, Prokaryotes: the unseen 
majority. Proc Natl Acad Sci U S A, 1998. 95(12): p. 6578-83. 
2. Centers for Disease Control and Prevention, Antibiotic resistance threats in the 
United States. 2013. 
3. Makita, K., et al., Risk assessment of staphylococcal poisoning due to 
consumption of informally-marketed milk and home-made yoghurt in Debre Zeit, 
Ethiopia. Int J Food Microbiol, 2012. 153(1-2): p. 135-41. 
4. Jordan, K., et al., Microbes versus microbes: control of pathogens in the food 
chain. J Sci Food Agric, 2014. 94(15): p. 3079-89. 
5. Sender, R., S. Fuchs, and R. Milo, Revised Estimates for the Number of Human 
and Bacteria Cells in the Body. PLoS Biol, 2016. 14(8): p. e1002533. 
6. Nicholson, J.K., et al., Host-gut microbiota metabolic interactions. Science, 2012. 
336(6086): p. 1262-7. 
7. Mueller, K., et al., The gut microbiota. Introduction. Science, 2012. 336(6086): p. 
1245. 
8. Tremaroli, V. and F. Backhed, Functional interactions between the gut 
microbiota and host metabolism. Nature, 2012. 489(7415): p. 242-9. 
9. Rakoff-Nahoum, S., K.R. Foster, and L.E. Comstock, The evolution of 
cooperation within the gut microbiota. Nature, 2016. 
10. Qin, J., et al., A metagenome-wide association study of gut microbiota in type 2 
diabetes. Nature, 2012. 490(7418): p. 55-60. 
11. Claesson, M.J., et al., Gut microbiota composition correlates with diet and health 
in the elderly. Nature, 2012. 488(7410): p. 178-84. 
12. Greenblum, S., P.J. Turnbaugh, and E. Borenstein, Metagenomic systems biology 
of the human gut microbiome reveals topological shifts associated with obesity 
and inflammatory bowel disease. Proc Natl Acad Sci U S A, 2012. 109(2): p. 594-
9. 
13. Ridaura, V.K., et al., Gut microbiota from twins discordant for obesity modulate 
metabolism in mice. Science, 2013. 341(6150): p. 1241214. 
14. Turnbaugh, P.J., et al., An obesity-associated gut microbiome with increased 
capacity for energy harvest. Nature, 2006. 444(7122): p. 1027-31. 
15. Alexander, C. and E.T. Rietschel, Bacterial lipopolysaccharides and innate 
immunity. J Endotoxin Res, 2001. 7(3): p. 167-202. 
16. Taylor, P.R., et al., Macrophage receptors and immune recognition. Annual 
Review of Immunology, 2005. 23: p. 901-944. 
17. Rabinovich, G.A., Y. van Kooyk, and B.A. Cobb, Glycobiology of immune 
responses. Ann N Y Acad Sci, 2012. 1253: p. 1-15. 
18. Hayashi, F., et al., The innate immune response to bacterial flagellin is mediated 
by Toll-like receptor 5. Nature, 2001. 410(6832): p. 1099-103. 
19. Ganal, S.C., et al., Priming of natural killer cells by nonmucosal mononuclear 
phagocytes requires instructive signals from commensal microbiota. Immunity, 
2012. 37(1): p. 171-86. 
 90 
20. Hall, L.J., et al., Natural killer cells protect against mucosal and systemic 
infection with the enteric pathogen Citrobacter rodentium. Infect Immun, 2013. 
81(2): p. 460-9. 
21. Subramanian, S., et al., Persistent gut microbiota immaturity in malnourished 
Bangladeshi children. Nature, 2014. 510(7505): p. 417-21. 
22. Mardis, E.R., Next-generation DNA sequencing methods. Annu Rev Genomics 
Hum Genet, 2008. 9: p. 387-402. 
23. Klindworth, A., et al., Evaluation of general 16S ribosomal RNA gene PCR 
primers for classical and next-generation sequencing-based diversity studies. 
Nucleic Acids Res, 2013. 41(1): p. e1. 
24. Berendsen, R.L., C.M. Pieterse, and P.A. Bakker, The rhizosphere microbiome 
and plant health. Trends Plant Sci, 2012. 17(8): p. 478-86. 
25. Procopio, R.E., et al., Antibiotics produced by Streptomyces. Braz J Infect Dis, 
2012. 16(5): p. 466-71. 
26. Cheng, Z., et al., Distinct single-cell signaling characteristics are conferred by 
the MyD88 and TRIF pathways during TLR4 activation. Sci Signal, 2015. 8(385): 
p. ra69. 
27. Mata-Haro, V., et al., The vaccine adjuvant monophosphoryl lipid A as a TRIF-
biased agonist of TLR4. Science, 2007. 316(5831): p. 1628-32. 
28. Piras, V. and K. Selvarajoo, Beyond MyD88 and TRIF Pathways in Toll-Like 
Receptor Signaling. Front Immunol, 2014. 5: p. 70. 
29. Watanabe, S., Y. Kumazawa, and J. Inoue, Liposomal lipopolysaccharide initiates 
TRIF-dependent signaling pathway independent of CD14. PLoS One, 2013. 8(4): 
p. e60078. 
30. Lund, M.E., et al., The choice of phorbol 12-myristate 13-acetate differentiation 
protocol influences the response of THP-1 macrophages to a pro-inflammatory 
stimulus. J Immunol Methods, 2016. 430: p. 64-70. 
31. Park, E.K., et al., Optimized THP-1 differentiation is required for the detection of 
responses to weak stimuli. Inflamm Res, 2007. 56(1): p. 45-50. 
 
 
